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ABSTRACT
IBordetella parapertussis is a cause of mild whooping cough in man and, in recent I
years, has been isolated from both healthy and pneumonic sheep. It has also been 
shown to interact synergistically with Pasteurella haemolytica in exacerbating 
ovine pasteurellosis. The relationship between ovine and human isolates of B. 
parapertussis has been examined at a taxonomic level and the presence of different 
types established. As the biological relevance of this differentiation is unknown, 
isolates of human and ovine origin were compared on the basis of their 
characteristics, including growth in ovine tracheobronchial washings (TBWs), their 
adherence to ovine and human cell lines and to ovine tracheal organ cultures, their 
interaction with ovine alveolai* macrophages, their LPS production and LPS 
interaction with antisera.
TBW are dilutions of the fluids that bathe the respiratory mucosae and are 
therefore the fluids in which B. parapertussis survive in vivo. This study showed 
that ovine B. parapertussis had the potential to grow in ovine TBW and suggested 
that the ability of ovine and human B. parapertussis to grow in TBW was host 
specific. Growth in nutrient broth also showed that human isolates grew more 
slowly than ovine isolates thereby suggesting that ovine and human B. 
parapertussis have different nutritional requirements.
In the diseased host, B. parapertussis is thought to adhere specifically to ciliated 
respiratory epithelium. A comparison of ovine and human B. parapertussis in 
terms of adherence to and invasion of non-ciiiated continuous cell lines showed no 
significant host cell preference. However, the adherence of ovine isolates to ovine
11
tracheal organ cultures, which contain viable ciliated cells, was greater than the
111
adherence of human isolates and therefore, the adherence of B. parapertussis to |
ciliated epithelial cells may be host specific.
Investigation of the interaction between B. parapertussis and continuous
yrespiratory cell lines as well as ovine alveolar macrophages revealed that the |
isolates which were more adherent to these cells were also more invasive. This %
study showed that both ovine and human B. parapertussis were capable of invasion
fand at least short-term survival within ovine alveolar macrophages.
Analysis of the LPS produced by ovine and human B. parapertussis revealed that I
all the ovine isolates tested produced a rough-type LPS, whereas, the majority of 
human isolates had a smooth-type LPS. The exception was the human isolate 
NCTC 5952 which produced a pattern on PAGE similar to those of ovine B. 
parapertussis. The use of PAGE for LPS analysis also revealed that the choice of 
bacterial growth medium affected the LPS pattern visualised on silver-stained gels. |
Western blots of ovine and human B. parapertussis LPS with rabbit sera raised |
against ovine and human isolates showed that the 0-antigens of the human B.
t
parapertussis LPS were immunodominant. These blots also showed that sera y
'I
raised against an ovine isolate reacted with all the isolates tested whereas, sera
raised against a human isolate reacted only with human B. parapertussis. In a
bactericidal assay anti-human B. parapertussis serum killed a high proportion of |
human isolates but only a small percentage of ovine isolates. In comparison, anti- B
ovine B. parapertussis serum killed approximately the same number of ovine and
human B. parapertussis. This bactericidal activity reflected the pattern of serum
interaction with B. parapertussis LPS on Western blots. It may be that the LPS of 
B. parapertussis cells is a target for the bactericidal activity of sera. ;
The use of LPS PAGE could not distinguish clearly between ovine and human 
isolates. However, the results of studies on growth, adherence to ovine tracheal 
organ culture and adherence to and invasion of ovine alveolar macrophages 
presented here strongly suggest that ovine and human B. parapertussis exhibit 
host-specific interactions.
IV
DECLARATION
The work described in this thesis was conducted at the Bacteriology Division of 
Moredun Research Institute, Edinburgh. The work presented here was carried out 
by myself, except where stated.
ACKNOWLEDGEMENTS
I would like to thank my supervisors, Willie Donachie and Roger Parton, for their 
encouragement, advice and constructive comments throughout this work. Many |
Ithanks to Helen Rowe for numerous helpful discussions, advice and assistance in 
the collection of ovine trachea, alveolar macrophages and tracheobronchial I
washings. Thanks also to Maddy Maley for advice on the bactericidal assay and 
discussions on the lipopolysaccharide analysis.
I am grateful to Jim Williams and the Clinical Department of Moredun Research
Institute, with thanks in particular to Jock McCracken, for arranging the
availability of sheep and carrying out the post-mortems. Thanks to Kay Hall and
Kay Quinn for providing the continuous-culture cells used in the adherence assays \
and David Snodgrass for providing porcine alveolar macrophages. I would also
like to thank Cathy Hau for the statistical analysis of results, John Small for
analysis of the TBW, Brian Easter for the production of photographs, Dave Buxton f
for the photographs of cell lines and macrophages and Audrey Gray for the |
production of the scanned images.
Lastly, but by no means least, I would like to thank my family and friends for their 
support and encouragement tliroughout this project.
Î''ÿ
VI
TABLE OF CONTENTS
ABSTRACT.........................................................................................................................  ii
DECLARATION................................................................................................................... v
ACKNOWLEDGEMENTS.....................................................................................   vi
TABLE OF CONTENTS............................................................................   vii
LIST OF FIGURES......................................................................................................  xii
LIST OF TABLES............................................................................................................... xv
ABBREVIATIONS............................................................................................................. xvi
PAGE
CHAPTER 1
1.6 Interaction with Pasteurella species................................................................. 17
vil
y
y,
sy
y;1
:
INTRODUCTION
1.1 Definition.............................................................................................................1
1.2 Discovery of Bordetella..................................................................................... 2
1.3. Taxonomy of the genus Bordetella....................................................................3
1.4 Isolation and nutrition.........................................................................................5
I
1.5 Diseases................................................................................................................9
1.5.1 Bordetella pertussis................................................................................ 9
1.5.2 Bordetella parapertussis........................................................................9
1.5.3 Bordetella hronchiseptica....................................................................14
1.5.4 Bordetella avium............................................................   15
1.5.5 Bordetella homesii................................................................................ 16
1.5.6 Bordetella hinzii.........................................................................   16
1.5.7 Bordetella trematum.....................    17
1.7 V irulence factors......................................................   18
1.7.1 Lipopoly saccharide (LPS)....................................................................20
1.7.2 Tracheal cytotoxin (TCT)..................................................................... 21
1.7.3 Heat-labile toxin (HLT)........................................................................ 21
1.7.4 Fimbriae................................................................................................. 22
1.7.5 Filamentous haemagglutinin (FHA).................................................... 23
1.7.6 Adenylate cyclase toxin (ACT)............................................................24
1.7.7 Pertactin (PRN).....................................................................................26
1.7.8 BrkA..................................................................................................... 26
1.7.9 Pertussis Toxin (PT)............................................................................. 27
1.7.10 Tracheal colonisation factor (TCF)..................................................... 28
1.7.11 Osteotoxin..............................................................................................28
1.7.12 Piracy of adhesins..........................................................  29
1.8 Adherence......................................................................................................... 29
1.8.1 Adherence assays..................................................................................29
1.9 Invasion........................................................................................     32
1.10 Interaction with host immune cells...............................................   33
1.11 Genetic regulation............................................................................................. 36
1.11.1 Antigenic modulation........................................................................... 36
1.11.2 Phase variation............................  ..37
1.12 Vaccines.............................................................................................................37
1.13 Respiratory tract............................................................................................... 39
1.13.1 Structure of the respiratory tract..........................................................39
1.13.2 Composition of respiratory fluids.........................................................41
1.14 Aims of Thesis...................................................................................................43
CHAPTER 2 
MATERIALS AND METHODS
2.1 General methods................................................................................................ 44
2.1.1 Bacteria and culture conditions..........................................................44
2.1.2 Haemagglutination assay............................................   45
2.2 Growth studies.................................................................................................. 45
2.2.1 Collection of lung washings............................................................... 45
2.2.2 Growth experiments............................................................................46
2.2.3 Purification of IgG...............................................................................46
2.2.4 SDS-PAGE.......................................................................................... 47
2.2.5 Coomassie blue staining of SDS-PAGE gels for protein..................47
2.2.6 Silver staining of SDS-PAGE gels..................................................... 48
VIII
2.4 Invasion.............................................................................................................51
GROWTH OF OVINE AND HUMAN BORDETELLA PARAPERTUSSIS IN 
OVINE TRACHEOBRONCHIAL WASHINGS (TBW)
3.1 Introduction......................................................................................................59
3.2 Materials and methods..................................................................................... 59
3.3 Growth in ovine TBW monitored by viable counts.......................................60
3.4 Statistical analysis of growth of B. parapertussis..........................................65
3.5 Analysis of TBW..............................................................................................66
3.6 Further analysis of TBW 5.............................................................................. 67
3.7 API analysis...................................................................................................... 69
IX
' I
2.2.7 Western blotting 48 I
2.2.8 Analysis of TBW................................................................................. 49
2.2.9 API analysis........................................................................................ 49
2.3 Bacterial adherence........................................................................................... 50
2.3.1 Adherence assay using cell lines........................................................ 50
2.3.2 Adherence assay using tracheal organ culture.....................................51
2.5 Macrophage interaction....................................................................................52
2.5.1 Collection and culture of alveolar macrophages................................ 52
2.5.2 Phagocytosis assay............................................................................. 53
2.5.3 Adherence to macrophages...................................................................53 7
2.5.4 Intracellular bacteria within macrophages...........................................54
2.5.5 Intracellular survival of bacteria in macrophages............................... 54
2.6 Lipopolysaccharide (LPS) analysis 55 |
2.6.1 LPS preparation 55 i |
2.6.2 PAGE for LPS 55 >1
2.6.3 LPS silver stain.....................................................................................56
2.6.4 Western blotting 56 i
2.7 Bactericidal assay..............................................................................................57
2.8 Statistical analysis.........................................................................................   58 A
CHAPTERS
■I
3.8 Discussion.......................................................................................................... 70
CHAPTER 4
ADHERENCE OF OVINE AND HUMAN BORDETELLA PARAPERTUSSIS 
TO CELL LINES AND OVINE TRACHEAL ORGAN CULTURES
4.1 Introduction...................................................................................................... 75
4.2 Materials and methods..................................................................................... 76
4.3 Haemagglutination assay................................................................................. 76
4.4 Adherence to ovine and human cell lines....................................................... 77
4.5 Invasion of cell lines.........................................................................................79
4.6 Adherence to ovine tracheal organ culture..................................................... 81
4.6.1 Interaction of HI supernate and P. haemolytica A 2 ........................... 83
4.7 Discussion........................................................................................................ 86
CHAPTER 5
INTERACTION OF OVINE AND HUMAN BORDETELLA 
PARAPERTUSSIS WITH ALVEOLAR MACROPHAGES
5.1 Introduction........................................................................................................ 94
5.2 Material s and methods...................................  94
5.3 Adherence of B. parapertussis to ovine alveolar macrophages....................... 95
5.4 Macrophages uptake of B. parapertussis......................................................... 95
5.5 Survival of B. parapertussis within ovine alveolar macrophages................... 99
5.6 Effect of opsonisation on phagocytosis...........................................................101
5.6.1 Bacterial adherence following opsonisation..................................... 101
5.6.2 Bacterial uptake following opsonisation.......................................... 104
5.6.3 Survival within macrophages following opsonisation.....................105
5.7 Effect of prolonged incubation on intracellular survival................................ 108
XI
" B?
5.8 Discussion........................................................................................................ 110
CHAPTER 6
COMPARISON OF OVINE AND HUMAN BORDETELLA 
PARAPERTUSSIS LIPOPOLYSACCHARIDE
6.1 Introduction...................................................................................................... 119
6.2 Materials and methods......................................................................................119
6.3 LPS PAGE........................................................................................................ 120
6.4 Western blots of LPS........................................................................................124
6.5 Bactericidal assay............................................................................................. 126
6.6 Discussion.........................................................................................................127
CHAPTER 7
GENERAL DISCUSSION I7.1 Discussion 133 I
References# *#*#*#*##*#*#####«####«###### #*###### ###«##«####*###############*########*$*##$###*##*###*#####*#*######*# 140
Appendix I
Methodological recipes
Appendix II
Raw data
LIST OF FIGURES 
PAGE
1.1 Diagram of human respiratory tract. 40
3.1 Growth of ovine (HI and K2) and human (B285 and NCTC 10520) 61
B. parapertussis in ovine TBW 1.
3.2 Growth of ovine (HI and K2) and human (B285 and NCTC 10520) 61
B. parapertussis in ovine TBW 2.
3.3 Growth of ovine (HI and K2) and human (B285 and NCTC 10520) 62
B. parapertussis in ovine TBW 3.
3.4 Growth of ovine (HI and K2) and human (B285 and NCTC 10520) 62
B. parapertussis in ovine TBW 4.
3.5 Growth of ovine (HI and K2) and human (B285 and NCTC 10520) 63
B. parapertussis in ovine TBW 5.
3.6 Growth of ovine (HI and K2) and hmnan (B285 and NCTC 10520) 64
B. parapertussis in nutrient broth.
3.7 Decline of viable ovine (HI and K2) and human (B285 and NCTC 64
10520) B. parapertussis in PBS.
3.8 IgG purified from TBW 5 visualised using silver stain. 68
4.1 Percentage adherence of ovine and human B. parapertussis to ovine 78
(FLT and FLL) and human (MRC-5) cell lines.
4.2 Percentage invasion of ovine (FLL and FLT) and human (MRC-5) 80
cell lines by ovine and human B. parapertussis.
4.3 Scamiing electron micrograph of ovine B. parapertussis isolate C 82
adhering to the cilia of ovine tracheal organ culture.
4.4 Percentage adherence of ovine and human B. parapertussis and P. 84
haemolytica A2 to ovine tracheal ring organ culture.
4.5 Percentage adherence of P. haemolytica A2 to ovine tracheal ring 85
organ culture following incubation with B. parapertussis HI culture 
supernatant.
X ll
4.6 Control experiment - percentage adherence of P. haemolytica A2 to 85 
ovine tracheal rii 
cyclodextrin liquid.
Xlll
1,
;
ng organ culture following incubation with
5.1 Adherence of ovine (HI and K2) and human (B285 and NCTC 96
10520) B. parapertussis to ovine alveolar macrophages.
5.2A Photographic representation of R  A HI interaction with 98 T
ovine alveolar macrophages using methanol fixation where both 
intracellular and extracellular bacteria can be visualised.
...yS
5.2B Photographic representation of R H I  adhering to 98
ovine alveolar macrophages using formol saline fixation
5.3 Phagocytic survival of B. parapertussis after 90 min incubation 100
compared with the inoculum used.
.
5.4 Percentage adherence of ovine B. parapertussis HI to macrophages 102
following opsonisation.
5.5 Percentage adherence of ovine B. parapertussis K2 to macrophages 102
following opsonisation.
5.6 Percentage adherence of human B. parapertussis B285 to 103
macrophages following opsonisation.
5.7 Percentage adherence of human B. parapertussis NCTC 10520 to 103
macrophages following opsonisation.
5.8 Survival of ovine B. parapertussis HI within in ovine alveolar 106
macrophages following opsonisation.
5.9 Survival of ovine B. parapertussis K2 within ovine alveolar 106
macrophages following opsonisation,
5.10 Survival of human R A  B28 5 within ovine alveolar 107
macrophages following opsonisation.
5.11 Survival of human B. parapertussis NCTC 10520 within ovine 107 g
alveolar macrophages following opsonisation.
5.12 Survival of ovine (HI and K2) and human (B285 and NCTC 10520) 109
B. parapertussis within ovine alveolar macrophages over 48 h. %
5.13 Survival of ovine (HI and K2) and human (B 85 and NCTC 10520) 109
B. parapertussis within porcine alveolar macrophages over 48 h. f
6.1 12 % acrylamide PAGE of LPS of ovine and human B. 121
parapertussis extracted from cyclodextrin liquid cultures visualised 
using silver staining.
6.4 14 % acrylamide PAGE of LPS of ovine and human B. 122
parapertussis extracted from nutrient broth cultures visualised using 
silver staining.
XIV
6.2 14 % acrylamide PAGE of LPS of ovine and human B. 121
parapertussis extracted from cyclodextrin liquid cultures visualised
using silver staining.
6.3 12 % acrylamide PAGE of LPS of ovine and human B. 122
parapertussis extracted from nutrient broth cultiues visualised using 
silver staining.
6.5 Western blot of ovine and human Bordetella parapertussis LPS 125 |
probed with rabbit sera raised against ovine isolate C.
6.6 Western blot of ovine and human Bordetella parapertussis LPS 125
probed with rabbits sera raised against human isolate NCTC 10520.
LIST OF TABLES
-;a;
1.1 Characteristics of Bordetella species.
1.2 Virulence factors produced by Bordetella species.
2.1 List of bacterial isolates.
PAGE
7
19
44
3.1 Significance of comparison of human vs. ovine B. parapertussis 65
growth in various fluids at each time point using the Mann-Whitney
test.
3.2 Significance of the comparison of ovine and human B. parapertussis 66
growth in fluids using repeated measures analysis of variance.
3.3 Analysis of ovine TBW for potential nutrients 67
3.4 API ZYM results of ovine and human B. parapertussis 70
4.1 Haemagglutination of sheep red blood cells by ovine and human B. 76
parapertussis.
4.2 B. parapertussis invasion of FLT cells grown in different media. 81
5.1 Comparison of ovine macrophage uptake of ovine and human B. 97
parapertussis.
5.2 Survival of phagocytosed B. parapertussis, expressed as % of 99
intracellular bacteria.
5.3 % Intracellular bacteria within ovine macrophages following 104
opsonisation with the following sera and TBWs.
5.4 % Survival of phagocytosed B. parapertussis following opsonisation 105
with the following fluids and sera. The survival is expressed as % of 
intracellular bacteria.
:
XV
- g
ABBREVIATIONS
ACT - Adenylate cyclase toxin 
BG - Bordet-Gengou 
Bvg - Bordetella virulence gene 
BWB - Blot wash buffer 
cfu - colony forming units 
CL - cyclodextrin liquid 
DNA - Deoxyribonucleic acid 
DW - Distilled water
EDTA - Diaminoethanetetra-acetic acid disodium salt 
EMEM - Eagle’s minimum essential medium 
FBS - Foetal bovine serum 
FFIA - Filamentous haemagglutinin 
FLL - Foetal lamb lung 
FLT - Foetal lamb turbinate
FIEPES - N-[2-Hydroxyethyl]piperazine-N’-[2-ethanesulfonic acid]
HLT - Heat-labile toxin 
HLY - Haemolysin 
IgG - Immunoglobulin G 
IgA - Immunoglobulin A 
IS - Insertion sequence 
kDa - Kilodalton 
LPS - Lipopolysaccharide
8■ "8
xvi ::8
LS - Lamb serum
MEE - Multilocus enzyme electrophoresis
■IMRI ~ Moredun Research Institute 
NB - Nutrient broth
PAGE - Polyacrylamide gel electrophoresis 
PBS - Phosphate buffered saline 
PRN - Pertactin 
PT - Pertussis toxin 
SDS - Sodium dodecyl sulphate 
SPF - Specific pathogen-free 
TBS - Tris-buffered saline 
TTBS - Tween tris-buffered saline 
TBW - Tracheobronchial washings 
TCF - Tracheal colonisation factor 
TCT - Tracheal cytotoxin
TEMED - N,N,N’,N’- tetramethylethylenediamine 
TPB - Tryptose phosphate broth |
.■I
TRIS - ( TRIS [ hydroxymethyl] amino-methane)
xvii
CHAPTER 1 
INTRODUCTION
Much of the research on the genus Bordetella has been carried out on Bordetella 
pertussis and B. hronchiseptica. B. parapertussis and B. avium have not been 
widely studied and are usually included in experiments only as comparators with 
the other Bordetella species. The pathogenicity of B. parapertussis is assumed to 
be much the same as B. pertussis for they both cause whooping cough in man, 
although at different severities. However, the recent isolation of R. parapertussis 
from sheep has suggested this bacterium may be a more versatile pathogen than 
previously thought.
1.1. Definition
Bordetella species are aerobic, gram-negative cocco-bacilli (0.3-0.5 pm x 0.5-2.0 
pm). Until recently, they were considered to be obligate respiratoiy tract 
pathogens but it has been shown that B. hronchiseptica and B. avium have the f
capacity to grow and survive outside their hosts in low nutrient conditions (Porter
and Wardlaw, 1993). Moreover, the latest additions to the Bordetella genus, B.
Ahinzii, B. holmesii and B. trematum have all been isolated from body sites other 
than the respiratory tract.
1.2. o ï Bordetella
Diseases that may have been caused by Bordetella species have been recognised 
for centuries but the causative organisms were not isolated until the 20th century.
Bordet and Gengou first isolated B. pertussis in 1906 using potato-glycerol agar 
containing 50% blood. Since then, six other Bordetella species have been 
recognised.
In 1910, Ferry isolated B. hronchiseptica (originally Bacillus hronchicanis) from 
the respiratory tract of dogs with distemper. B. hronchiseptica is now recognised i
to be an important respiratoiy pathogen of many wild and domestic animals as well 
as an opportunistic pathogen of man (Mesnard et al, 1993).
B. parapertussis (originally Bacillus parapertussis) was discovered by Eldering 
and Kendrick in 1938 and described as a species closely related to both B. pertussis
I
and B. hronchiseptica and capable of causing mild whooping cough. Until 1987 it I
was thought that B. parapertussis was an obligate human pathogen but B. 
parapertussis~\ik.Q organisms have since been isolated from the respiratoiy tract of 
sheep in New Zealand (Cullinane et al, 1987) and Scotland (Porter et a l, 1994).
In 1967, Filion et a l isolated a B. hronchiseptica-likQ organism fr'om respiratoiy 
disease in turkey poults. Flinz et al (1978) reported similar findings and in 1984 
Bordetella avium was proposed by Kersters et al (1984) as the name of the y
causative organism. Bordetella holmesii was proposed as the name for a group of 
non-oxidising gram-negative bacteria isolated since 1983 fr'om human blood 
cultures (Weyant et al, 1995). Some of these patients had underlying conditions 
that may have enhanced their susceptibility to infection. However, it is not yet
1.3. Taxonomy of the genus Bordetella
Since their discoveiy, Bordetella species have been allocated to many different 
genera. The various species have been members of the Alcaligenes, Bacillus, 
Haemophilus and Brucella genera. With the advance of molecular biology, studies 
have detemiined that Bordetella are most closely related to Alcaligenes and are 
now assigned to the beta-2 subdivision of Proteobacteria (Weyant et a l, 1995).
The first Bordetella species to be identified was B. pertussis. This was initially 
named Bacillus pertussis. When B. parapertussis was discovered in 1938 
(Eldering and Kendiick, 1938) this was given the name Bacillus parapertussis. 
Later, both these organisms were assigned to the Haemophilus genus. B.
:■Ï
known whether B, holmesii is capable of infection in a healthy host or if it is an 
opportunistic pathogen. ICookson et al. in 1994 proposed the name Bordetella hinzii for a bacterium 
isolated from an immunocompromised patient. Their investigations showed that 
this isolate was similar to, but not identical with, B. avium. In 1995, Vandamme et 
al. published a report on strains of B. hinzii isolated from the respiratory tracts of
,:7
turkeys, chickens and humans. Experimental infection of young turkeys and 
chickens found the organism now known as B. hinzii to be non-pathogenic 
(Jackwood et al, 1995).
The most recent addition to the Bordetella genus is Bordetella trematum 
(Vandamme et a l, 1996). This was isolated from wounds and ear infections in 
humans.
ïhronchiseptica was originally assigned to the genus Alcaligenes (Bergey, 1925).
This was followed by a move to the genus Brucella (Topley and Wilson, 1929) and |
then to Haemophilus (Wilson and Miles, 1946, cited by Goodnow, 1980). It was y
some years later that this bacterium was renamed B. hronchiseptica. B. avium was
joriginally assigned to the Alcaligenes faecalis species and was then described as a 
B. hronchiseptica-likQ organism until 1984 when it was given its current species 
designation. The more recently identified species have been assigned directly to 
the Bordetella genus.
Studies have shown the genus Bordetella to contain a closely related group of 
bacteria and there are still questions raised about the accuracy of having so many 
individual species rather than subspecies of a single species.
Johnson and Sneath (1973) analysed 134 features of B. pertussis and B. 
parapertussis and concluded, on the basis of a numerical taxonomy study, that they 
ai'e the most closely related of the Bordetella species. However, by analysing the 
electrophoretic mobilities of certain metabolic enzymes, Musser et al. (1986) 
reported that B. parapertussis was more closely related to B. hronchiseptica. This 
was supported by analysis of insertion sequences by van der Zee et al. (1997) who 
suggested that B. parapertussis should be assigned as a subspecies of B. 
hronchiseptica. The similarity between B. parapertussis and B. hronchiseptica 
was further demonstrated by the finding that both have a transcriptionally-silent 
pertussis toxin gene (Arico and Rappuoli, 1987). The close relationship of B. 
pertussis, B. parapertussis and B. hronchiseptica was reported by De Ley et al.
(1986) who found that these tlrree species could not be differentiated from each
other by the mean G+C contents of their genomic DNAs or by testing the thermal
stability of DNA-rRNA hybrids (using labelled rRNA from B. hronchiseptica).
In comparison, B. avium is more easily differentiated from B. pertussis. Its 
distinctiveness from B. pertussis, B. parapertussis and B. hronchiseptica is A
demonstrated by the lower G + C content of 61-62.6 mol% of its DNA compared
1.4. Isolation and nutrition
Bordetella species. In 1977, Regan and Lowe developed a charcoal-based agar
with a range of 67.7%-69.5% for the other tested species (Kersters et a l, 1984). |B':'
This difference is reinforced by the absence of a pertussis toxin gene (Aiico and 
Rappuoli, 1987) and lack of production of adenylate cyclase toxin (Hewlett and 
Gordon, 1988).
Many studies have been canied out on the species designation of the genus 
Bordetella using a variety of methods: deoxyribonucleotide sequencing (Kloos et 
al, 1981); cultural and biochemical characteristics (Hinz et a l, 1983); multilocus 
enzyme electrophoresis (Musser et a l, 1986); ribonucleic acid hybridisation (De 
Ley et a l, 1986); insertion sequence analysis (van der Zee et a l, 1996, 1997).
Although various methods have been used, all the studies came to the conclusion 
that B. pertussis, B. parapertussis and B. hronchiseptica are a single genospecies |
and that B. avium is a true species. For convenience of presentation however, the 
specific names will be used in this thesis.
Bordet and Gengou were the first to achieve the growth of B. pertussis on solid 
media using a glycerol-potato extract medium containing 50% blood (Bordet and ■,.a
-8Gengou, 1906). Modified versions of this medium are still in use for the growth of a|
supplemented with 10% defibrinated horse blood and 40 pg ml"’ cephalexin. This 
medium is still recommended today for the primaiy isolation and transport of B. 
pertussis.
Stainer and Scholte (Stainer and Scholte, 1971) developed a liquid medium 
containing glutamic acid and pro line which enlianced the growth of B. pertussis. 
Although this was suitable for the growth of large quantities of B. pertussis, it only 
supported growth from a large inoculum. The addition of heptakis (2,6-0- 
dimethyl) p-cyclodextrin, which fbims water soluble complexes with hydrophobic 
molecules such as fatty acids, enabled the growth of B. pertussis from a small 
inoculum. This also increased the production of PT, FHA and ACT, which were 
released into the culture supemate (Imaizumi et a l, 1983; Sato et a l, 1984). The 
increased production of virulence factors in this medium facilitated the production 
of acellular vaccines.
B. pertussis is the most fastidious of the Bordetella species. This species can only 
be grown on specialised media such as Bordet-Gengou agar, Regan-Lowe agar and 
cyclodextrin liquid. The other bordetellae are able to grow on blood agar, nutrient 
agar and MacConkey’s agar. Growth of B. pertussis is inlribited by unsaturated 
fatty acids which are found in most media (Pollock, 1947), colloidal copper 
sulphide (Proom, 1955) and contaminating detergents from glassware. However, 
the addition of starch, albumin and charcoal reduces the effects of these inhibitors 
(Jebb and Tomlinson, 1957; Wilson, 1963) on B. pertussis. The growth 
characteristics of Bordetella species are detailed in Table 1.1.
Bordetella species have simple nutritional requirements. Proom (1955) studied
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grow in a mixture of glutamic acid, proline and leucine while B. parapertussis 
required added cystine and methionine and B. pertussis required, in addition, 
alanine, asparagine and serine (Proom, 1955). Goldner et al, (1966), however, 
found that glutamic acid and proline were the only amino acids whose absence 
limited the growth of B. pertussis. B. bronchiseptica and B. avium can also utilise 
carhon sources such as lactate and citrate (Proom, 1955; Kersters et a l, 1984). No 
infonnation is available on the nutritional requirements of the other Bordetella 
species.
I
B. pertussis, B. parapertussis and B. bronchiseptica and found that these species 
all had an absolute requirement for nicotinic acid. This was also found to he the
;
case for B. avium (Kersters et al., 1984). However, Porter et al (1991) T
Î'demonstrated that B. bronchiseptica could grow, to some extent, in phosphate- |
buffered saline and natural waters without the addition of nicotinic acid.
Amino acids are required as a carbon and nitrogen source for B. pertussis, B. 7
parapertussis, B. bronchiseptica and B. avium (Proom, 1955; Kersters et al., 4
1984). Glutamic acid is the preferred carbon and nitrogen source of R. pertussis, |
B. parapertussis and B. bronchiseptica and is the first to be utilised in simple ; J
amino acid mixtures but can be replaced by a-ketoglutaric acid (Proom, 1955; Jebb 
and Tomlinson, 1955, 1957; Rowatt, 1955). An organic form of sulphur such as 
cysteine, cystine or methionine is also required by B. pertussis (Proom, 1955; Jebb ♦
!■and Tomlinson, 1957). B. bronchiseptica has the simplest nutritional needs. It can
1.5. Diseases
B. pertussis is the causative agent of whooping cough, a respiratoiy infection that
1.5.2. Bordetella parapertussis
B. parapertussis is generally considered to cause a milder foim of whooping cough
1.5.1. Bordetella pertussis
mainly affects young children. This organism is transmitted by aerosol droplets
and has an initial incubation period of about 7 days before the onset of symptoms f|
(Wardlaw, 1990). The typical clinical features of this disease include fever and a
■I
paroxysmal cough that is often followed by the distinctive inspiratory whoop. This |
may result in vomiting and apnoea that in turn can lead to respiratory i
complications and CNS disturbances (Parton, 1998). In some countries, including 
the UK, epidemics of whooping cough have been reported to occur in cycles with 
the epidemic peak occurring every 3-4 years (Lautrop, 1971).
Before vaccines were developed, whooping cough was a major cause of infant 
death across the glohe. Since vaccination was introduced, the mortality rate has 
fallen considerably and, in developed countries with an extensive vaccination 
programme, the number of whooping cough cases are at a low level (Willems and 
Mooi, 1996). However, in unvaccinated populations, whooping cough is 
responsible for severe morbidity and mortality with an estimated 60 million cases 
and >0.5 million deaths globally per annum (Muller et a l, 1986).
,:li.
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than B. pertussis. Despite the absence of pertussis toxin (PT), B. parapertussis is 
capable of causing a severe disease (Heininger et a l, 1994) and in some cases 
death (Zuelzer and Wheeler, 1946; Liimeman and Periy, 1977). This suggests that 
PT is not necessary for severe cases of whooping cough.
In the USA and Europe, B. parapertussis has been reported to cause 5% of 
Bordetella infections (Willems and Mooi, 1996). However, in Eastern Europe the 
figure is as high as 30% (Neimark et a l, 1961) despite the use of whooping cough 
vaccines in these countries. This supports the findings of Klielef et a l (1993a) 
who demonstrated that there is no cross protection between B. pertussis and B. 
parapertussis antigens.
The milder disease most often associated with B, parapertussis may result in a sub- 
clinical infection and will often go unnoticed. A study of the incidence of B. 
parapertussis infection in children in Moscow in 1959 found that 50% of the 
children tested were asymptomatic carriers of B. parapertussis (Neimark et a l, 
1961). The same study also observed that 30% of bacteria isolated from suspected 
cases of pertussis were wrongly identified as B. pertussis when in fact the causative 
agent was B. parapertussis. However, the true figure representing B. parapertussis 
infection is not known. The closest indication of the prevalence of B. 
parapertussis infection is given by the results of serological studies carried out in 
Europe (Vysoka-Burianova, 1963) where more than 50% of the adult population 
had antibodies to B. parapertussis, and the USA (Flosdorf et al, 1942) which 
found that 91% of the adults tested had antibodies to B. parapertussis. This 
suggests that B. parapertussis is circulating throughout most of the population and 
thus creating a potential reservoir of infection.
■ f i
It is also possible that B. pertussis and B. parapertussis cause a co-infection.
ft
Kawai et al. (1996) reported the persistent colonisation of the lungs and trachea of I
mice by B. parapertussis when these mice had been infected with both B. pertussis 
and B. parapertussis. A study in the USA (Linnemann and Perry, 1977) 
documented cases of B. parapertussis infection with lymphocytosis. However, B. 
parapertussis does not produce PT, which is the lymphocytosis-promoting factor.
Some of the patients family were tested for the culture of B. pertussis and two- 
thirds tested positive. This suggests that the patients had come into contact with B. %
pertussis, which facilitated the infection of the host by B. parapertussis. Further U
studies have also reported dual infections or simultaneous outbreaks of these two |
organisms (Eldering and Kendrick, 1938; Lautrop, 1958; Donchev and Stoyanova,
1961; Taranger ef n/., 1994). |
B. parapertussis was previously thought to be an obligate human respiratory tract 
pathogen. However, in 1987 Cullinane et al. isolated B. parapertussis in New 
Zealand from nasal swabs, bronchial washings and lung tissue of both healthy and 
pneumonic lambs but not horn adult sheep. They suggested that the failure of 
others to isolate this bacteria from lambs may have been because lung tissue is the 
material usually investigated from pneumonic lamhs, yet this tissue provided a low 
rate of recovery of R. parapertussis. Also, an incubation time of up to seven days 
was required and if other bacteria are present, persistent subculturing may be
necessaiy before a pure culture can be obtained for identification. The
identification of these isolates by Cullinane et al. (1987) was based on biochemical 
reactions. They found that these ovine isolates were indistinguishable from known 
B. parapertussis except for the speed of the urease reaction and lack of pigment
11
production on peptone agar, which are more characteristic ofB.  bronchiseptica.
Porter et al (1994) reported the isolation of B. parapertussis from the lungs of
IIboth healthy and pneumonic adult sheep in Scotland. As with Cullinane et al
(1987), most of their ovine isolates produced a fast urease reaction. However, all
bronchiseptica-\i]fiQ than B. parapertussis-like based on the results of their 
biochemical analysis and the finding that these isolates were motile whereas all the 
other B. parapertussis isolates tested (both human and ovine) were non-motile. 
Porter et al (1991) reported that B. bronchiseptica was capable of growth in
12
of the Scottish ovine isolates did produce browning on tyrosine agar (except batch IIK). Porter et al (1994) suggested that the isolates of batch K were more B. |
I I
■t
phosphate-buffered saline (PBS). However, like the B. parapertussis isolates S
tested, the isolates of batch K did not grow in PBS and they did not reduce nitrate, 
whereas, the m^ority of the B. bronchiseptica reference strains did.
?Multilocus enzyme electrophoresis (MEE) separated the human and ovine B.
fparapertussis and isolates of B. bronchiseptica into different groups (Porter et ah,
1994). On the basis of these analyses they concluded that the bacteria isolated
from the lungs of adult sheep were B. parapertussis, except hatch K which required 7
more study, and suggested the potential for a possible zoonotic infection of man.
Study of the EPS, fatty acid patterns and antibiotic sensitivity (Porter et al, 1995c) 
failed to differentiate clearly between isolates from different host species.
Interestingly, analysis of the EPS and antibiotic sensitivity found the human isolate
NCTC 5952 to be more similar to ovine than human isolates. This result is 
.reflected in the pulsed-field gel electrophoresis analysis of Porter et a l (1996)
|i;
where banding pattern of NCTC 5952 was identical to some of the ovine rather
than human isolates. The rest of the B. parapertussis isolates tested indicated that 
human and ovine isolates of B. parapertussis are genetically distinct and that 
variation exists within isolates from the same host species. The idea of two distinct $
populations of B. parapertussis is supported by the work of van der Zee et aL |
(1996) who, by DNA fingerprint analysis using insertion sequence (IS) element -'ft
IS 1001, revealed that ovine B. parapertussis are distinct from human B.
:
parapertussis. They also examined the presence of IS1002 within Bordetella
species and found that IS1002 was present in both B. pertussis and human B. *'f
,.;ftparapertussis. In contrast, \S1002 was absent from ovine B. parapertussis. Also,
IS-associated restriction fragment length polymorphism analysis revealed that 
,ovine B. parapertussis are genetically more polymorphic than human B. ftft
gparapertussis. This suggests that human B. parapertussis diverged from a single
clone more recently than ovine B. parapertussis, van der Zee et al. (1996) "f
'-'ft:
concluded that ovine and human B. parapertussis appeared to have evolved 
independently from B. bronchiseptica. Further study by van der Zee et al. (1997) 
using MEE and analysis of IS distribution suggested that human B. parapertussis 
derived from a pig strain of B. bronchiseptica and that ovine B. parapertussis 
probably evolved from B. bronchiseptica earlier than human B. parapertussis. I
Studies on the New Zealand ovine isolates of B. parapertussis demonstrated their 
pathogenicity and ability to cause pneumonia in mice (Chen et al, 1989) and |
colostrum-deprived lambs (Chen et al, 1988a and 1988b). These experiments 
demonstrated that ovine B. parapertussis targeted the alveolar macrophages and 
alveolar epithelium and could cause pulmonary lesions in both sheep and mouse 
models. This could compromise the pulmonary defence mechanisms and allow the
13
invasion of the lower respiratory tract by other pathogens such as Pasteurella 
haemolytica, which is capable of causing a more severe pneumonia. Chen et al
(1990) also showed that cell-free extracts of ovine B. parapertussis could cause I
pneumonia in mice. This suggests that the extracelluar virulence factors of ovine i;
parapertussis may be involved in causing the lesions associated with the type of 4
=s
pneumonia seen using whole cells. These findings also suggest that the toxins of 
B. parapertussis compromise the host and therefore enable secondary infections to TItake place. Ï
: |
Experiments using mice showed that the combined administration of ovine B. %
parapertussis and P. haemolytica produced a more severe bronchopneumonia than 1
when either agent is given alone. The results suggest either a synergy between the 
two organisms (Jian et a l, 1991) or that B. parapertussis predisposes the host to P,
14
haemolytica infection (Porter et al, 1995b). Further work has shown the same 
predisposition effect using SPF lambs (Porter et a l, 1995a).
I
1.5.3, Bordetella bronchiseptica
Unlike B. pertussis and B. parapertussis, B. bronchiseptica has a broad host range.
This bacterium has been isolated from many different mammals including dogs, 
cats, horses, monkeys and humans but it is the role of B. bronchiseptica in atrophic
1rhinitis of pigs that has received the most interest. ft
I
Atrophic rhinitis in swine causes a major economic loss worldwide and may be
: "ft
found in 40% or more of swine herds in the USA (Harris and Switzer, 1972). B. 4
bronchiseptica alone can cause a mild turbinate atrophy in pigs (Cross and Claflin,
1.5.4. Bordetella avium
This is the causative agent of turkey coryza which is a highly contagious disease of 
turkey poults and secondary infections that arise can result in a mortality rate of
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1962; Bras sine et a l, 1976) but the more severe disease is caused by a synergy
■' ft"with Pasteurella multocida. B. bronchiseptica produces toxins that can damage A
the respiratory tract of pigs. This may then predispose them to P. multocida lê.
(Rutter, 1985) and possibly result in a more severe infection.
B. bronchiseptica also causes infectious tracheobronchitis in dogs (Goodnow,
1980; Bemis, 1992) which is a highly contagious disease that affects all ages of 
dogs and is commonly found in dogs kept in close confinement (Bemis et a l,
1977). This bacterium has also been reported as the cause of 10% of all feline 
respiratoiy infections (Snyder et a l, 1973). B. bronchiseptica has occasionally 
been associated with human infection, mostly through contact with an infected ft"ft"
animal, and in these cases it is usually an opportunistic infection in an 
,immunocompromised host (Ghosh and Tranter, 1979; Woolffey and Moody, 1991;
ft
Gueirard et a l, 1995). !
B. bronchiseptica is a somewhat unusual Bordetella species in that it can cause 
disease in a wide range of animals. This species has also been reported to survive 
in nutritionally-deficient enviromnents. Porter and Wardlaw (1993) noted the 
long-term survival and growth of R. bronchiseptica in PBS and lakewater at 10°C
ftfor up to 24 weeks. This suggests that there may be reservoirs of infection in the
ft:
environment and has implications for the source of R. bronchiseptica infections.
I
1.5.5. Bordetella holmesii
B. holmesii is one of the newer species of the genus Bordetella. It has been
This species has been isolated from both humans and poultry (Cookson et a i, 
1994; Vandamme et a l, 1995; Funlce et a l, 1996). Two strains were isolated
;
75% (Simmons et a l, 1983). Although B. avium is usually associated with
s'"
respiratory infections of turkeys it has also been isolated from other avian species 
including chickens (Jackwood et a l, 1995; Kersters et a l, 1984). Porter et al
t
(1991) briefly mentioned that B. avium is also capable of growing in PBS and 
natural fresh waters. These are low nutrient environments and the suiwival of B. ■ft■ftavium suggests a possible environmental source of infection.
isolated from blood cultures of mostly young adults (Weyant et al, 1995) and has 
been attributed as the cause of sepsis in an asplenic adolescent (Lindquist et al,
1995). Most of the subjects from whom this bacterium was isolated had an
ft',underlying condition that may have rendered them susceptible to an opportunistic 
infection.
1.5.6. Bordetella hinzii
repeatedly from a cystic fibrosis patient over a 3 year period (Funke et a l, 1996).
Another strain was the cause of bacteraemia in an AIDS patient (Cookson et a l, I
1994).
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1.5.7. Bordetella trematum
Little is known about the most recently discovered member of the Bordetella 
species, B. trematum. To date, Vandamme et a l (1996) have reported the isolation 
of the bacterium from wounds and ear infections in humans and presented the 
reasons for detennining it to be a Bordetella species based on analysis using both 
phenotypic and genotypic methods.
1.6. Interaction with Pasteurella species
:7:
.Two Pasteurella species have been associated with Bordetella infections. B.
bronchiseptica and P. multocida have a synergistic relationship in atrophic rhinitis
in pigs (Rutter, 1985) and B. parapertussis is reported to predispose sheep to P. «
haemolytica infection (Jian et al, 1991 ; Porter et a l, 1995a).
.P. haemolytica is a major cause of pneumonia in sheep worldwide and its impact
i,;;
has resulted in economic losses. This bacterium is found in the upper respiratory
tract of clinically healthy sheep and causes disease, usually when the host is
predisposed. Two possible causes of predisposition are environmental factors and 
.other infectious agents. Some outbreaks have been associated with changes in
17
weather and dipping but there have been no epidemiological surveys on the effect
of external factors on incidence of disease (Gilmour, 1992). Experimental 
investigations have produced disease in sheep when they have been pre-infected 
with a range of viruses (Gilmour and Gilmour, 1989). More recently, experiments 
have demonstrated that B. parapertussis predisposes specific-pathogen-free lambs
"1''À
to p. haemolytica infection and induces a more severe disease than when either 7?
agent is given alone (Porter et a l, 1995a). It is suggested that, as in atrophic
7rhinitis due to B. bronchiseptica, B. parapertussis produces a tracheal cytotoxin
that damages the cilia of the respiratory epithelium thereby creating an
accumulation of mucus. This could allow the establisliment of P. haemolytica
infection. In addition, the adenylate cyclase toxin of B. parapertussis may 4|
.interfere with macrophage function enabling P. haemolytica to overcome the host 7
defences.
1.7. Virulence factors
The members of the genus Bordetella produce a variety of virulence factors
1:including toxins and adhesins that are utilised in causing a respiratory tract 
infection. Not all of these factors are produced by all Bordetella species. Table 
1.2 is a summary of virulence factors produced by the different species. No 
infonnation is published on the vimlence factors, if any, produced by B. hinzii, B. 
holmesii or B. trematum.
Most of what is known of these virulence factors has been taken from studies 
canied out on B. pertussis. There may be subtle differences in the factors 
produced by the various Bordetella species hut their functions are assumed to be 
the same for all species.
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1.7.1. Lipopolysaccharide (LPS)
This is produced by all gram-negative bacteria. Like LPS produced by other 
bacteria, the LPS of bordetellae have the properties of pyrogenicity, adjuvanticity, 
stimulation of IL-1 and TNF, macrophage activation and mitogenicity (Chaby and 
Caroff, 1988; Watanabe et a l, 1990).
The LPS of B. pertussis and ovine B. parapertussis are of the rough type which has 
no 0-antigen, whereas the LPS of human B. parapertussis and B. bronchiseptica 
are both smooth types which have the 0-antigen (Peppier, 1984; Amano et al, 
1990; Brodeur et a l, 1993; van den Akker, 1998). The LPS of B. bronchiseptica 
has been reported to have structures in common with both B. pertussis and human 
B. parapertussis (Amano et a l, 1990). This was based on the fact that LPS from 
B. bronchiseptica reacted with antisera raised against B. pertussis and B. 
parapertussis while the B. pertussis and human B. parapertussis LPS’s were found 
to be serologically different from each other. In addition, SDS-PAGE revealed that 
the LPS of all tlrree species tested contained low molecular weight bands.
LPS is not included in the acellular vaccine preparations because of its endotoxic 
effects and it is generally not considered to be a protective antigen (Pittman, 1984). 
However, boiling whole-cell pertussis vaccine destroyed all but the heat-stable LPS 
yet the vaccine still protected mice against intranasal challenge with B. pertussis 
(Standfast, 1958) suggesting that the LPS does play a role in protective immunity.
20
1.7.2. Tracheal Cytotoxin (TCT)
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TCT is known to be produced by at least 4 of the Bordetella species, B. pertussis,
B. parapertussis, B. bronchiseptica and B, avium (Goldman, 1988). This toxin is 
derived from the peptidoglycan of the bacterial cell envelope and is released into 
the culture medium during the logarithmic phase of growth (Cookson et a l , 1989).
ITCT activity has been demonstrated in hamster tracheal organ cultures where it 
caused ciliostasis and ciliated cell extrusion as well as inhibition of DNA synthesis 
in hamster tracheal epithelial cell cultures (Goldman and Herwaldt, 1985).
Considering that the ciliated cells of the airways are responsible for the clearance 
of tracheal mucus and entrapped microorganisms, the loss of ciliary activity will 
result in the accumulation of mucus in the respiratory tract and enable the 
multiplication of bacteria. B. pertussis infection could therefore promote 
secondary infections of the respiratory tract by this mechanism. î
• ftThe toxic activity of TCT is due to its stimulation of IL-1 production by respiratory 
epithelial cells (Heiss et a l, 1993) which triggers the synthesis of nitric oxide in Ithe respiratory epithelium. Nitric oxide can be cytotoxic or cytostatic to cells 
including those of the respiratory epithelium (Heiss et a l, 1994). TCT has also
4
■ v'been shown to be toxic for human neutrophils and may therefore contribute to the
suiwival of B. pertussis in the aiiivays of the host (Cundell et a l, 1994). ;
1.7.3. Heat-Labile Toxin (HLT)
The HLT is a cytoplasmic protein that is produced by B. pertussis, B.
■1.7.4. Fimbriae
parapertussis, B. bronchiseptica and B. avium. It has yet to be determined whether 
the other Bordetella produce this toxin. The role of HLT in disease is unknown yet 
experiments in animals have shown it to be lethal, dermonecrotising (lida and 7
Okonogi, 1971) and vasoconstrictive (Endoh et a l, 1986). However, the HLT of I
7
B. bronchiseptica is suggested to have a role in atrophic rhinitis of pigs (Hanada et 7:/'
al, 1979; Horiguchi et a l, 1994).
HLT is inactivated by heating at 56°C for 30 min and, as a result, it is destroyed y
'7during whole-cell vaccine preparation. The mouse-toxicity test for whole-cell ipertussis vaccine was introduced to confirm that the HLT had been destroyed
(Pittman, 1952). These vaccines are effective against whooping cough, which ig
■7suggests that antibodies to HLT are not required for protective immunity. Indeed,
*B. pertussis mutants deficient in HLT are as virulent as the wild-type strains in a 
mouse model (Weiss and Goodwin, 1989).
The HLT produced by B. pertussis, B. parapertussis and B. bronchiseptica are 
identical genetically and biologically whereas there are differences between them 
and the HLT of B. avium (Walker and Weiss, 1994).
The fimbriae are produced by B. pertussis, B. parapertussis, B. bronchiseptica and
IB. avium. Three types of fimbriae are produced by Bordetella and are encoded by |
the genes/zm2,/i/7î3 miéfimX  (Cuzzoni et a l, 1990). fim2 tmdfim 3 are expressed 7
1':
by all of the species whereas yimX is silent in B. pertussis but is expressed in B. |
bronchiseptica (Rappuoli, 1994).
22
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Fimbriae of bacteria usually have a role in adhesion. However, this has not been 
clearly defined for the Bordetella species. Antibodies to fimbriae have been shown
-ftto block the adherence of B. pertussis to non-ciliated tissue culture cells but they
!:do not inhibit the adherence to ciliated cells which are the natrnal targets Û
(Tuomanen, 1988). 7V
; I'Fimbriae have been included in some of the acellular vaccine preparations 
(Willems and Mooi, 1996) although they have only been shown to protect mice
ft
against B. pertussis infection and their role in human disease is still not clearly 
defined.
ft
/ft
1.7.5. Filamentous Haemagglutinin (FHA)
:
The FHA of 5. pertussis is a 220kDa secreted protein that acts as one of the major
ft-
ftadhesins. There are tlrree binding domains of the FHA which detennine the 
different adherence mechanisms of B. pertussis. The carbohydrate-binding site
1enables the bacteria to adhere to the ciliated respiratory cells (Tuomanen et al,
1988) whilst the heparin-binding domain allows the adherence to non-ciliated cells |
(Menozzi et a l, 1991; Locht et a l, 1993). These two binding sites enable B. 
pertussis to bind to and colonise the respiratory tract of the host before establishing
ftan infection. A third domain is an Arg-Gly-Asp (RGD) region which promotes
adherence to the macrophage integrin CR3 (Reiman et a l, 1990). Intracellular ftK
uptake via CR3 does not trigger an oxidative burst (Wright and Silverstein, 1983).
:■7
Therefore, internalisation into the macrophage by this route may promote the I
intracellular survival of 5, pertussis and possibly create a reservoir of infection. ft
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The role of FHA as a major virulence factor of B. pertussis has promoted its J
inclusion in some acellular vaccine preparations. FHA immunisation of mice 7;
provided significant protection against aerosol challenge with B. pertussis (Cahill
■Iet a l, 1995) and reduced the levels of B. pertussis recovered from the lungs and 
trachea (Locht et a l, 1993).
: :/■B. parapertussis and B. bronchiseptica produce similar FHA proteins which are 
.surface-associated whereas the FHA of B. pertussis can be found secreted in the 7
I'culture supernatant (Locht et a l, 1993). However, there is a lack of antigenic
■5:
ft-cross-reactivity between the FHA produced by the different species. Immunisation f
Iwith FHA from B. pertussis does not protect mice from lung colonisation by B.
■ :j-.:
.parapertussis (Khelef et a l, 1993a) and although antibodies against the FHA of R.
ipertussis recognise whole cell lysates of B. pertussis they do not recognise whole- ft
cell lysates ofB. parapertussis ox B. bronchiseptica (Domenighini et a l, 1990).
1.7.6. Adenylate Cyclase Toxin (ACT) I
'"ft
The ACT of 5. pertussis is a bifunctional protein with both adenylate cyclase and 
haemolysin activity that can be found associated with the bacterial cell envelope
■7and also in the supernatant of bacterial cultures (Wolff er al, 1980). It is a member
of the RTX toxin family and like all of these it is pore-fbrming and cytolytic. The
C-terminal portion of the toxin confers the haemolytic activity and this penetrates 
.the target eukaryotic cell membrane and facilitates the transport of the N-terminal §-ftftportion into the target cell. The N-terminal portion is then cleaved, releasing the |
ft'/adenylate cyclase enzymic moiety which is then activated by the eukaryotic protein
I
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calmodulin. The active adenylate cyclase causes unregulated synthesis of cAMP 
and is cytotoxic to a range of cells including the immune-effector cells (Confer and 
Eaton, 1982; Hewlett and Gordon, 1988; Hewlett et al, 1991; Rogel and Hanski; 
1992). This enables B. pertussis to survive in the host and cause infection. The 
immuno-compromising action of the ACT could also result in the host becoming 
more susceptible to secondary infections (Confer and Eaton, 1982).
Studies on ACT in mice (Guiso et al, 1989) and in vitro (Hewlett and Gordon, 
1988) have confirmed that it plays an important role in B. pertussis infection. B. 
pertussis mutants lacking ACT have been shown to be less virulent than the wild- 
type strain (Weiss et a l, 1983) and displayed a decreased suiwival rate within 
human macrophages (Masure, 1992). Further work showed that mutants lacking 
adenylate cyclase or haemolytic activities were unahle to initiate infection (Khelef 
et a l, 1992).
The important role of ACT as a virulence factor of B. pertussis suggests that it 
would be useful as a component of acellular vaccines. Active immunisation of 
mice with purified adenylate cyclase-haemolysin protects mice against B. pertussis 
infection by significantly enhancing the clearance of the bacteria from the 
respiratory tract (Guiso et a l, 1991). However, it has been reported that the 
adenylate cyclase from B. pertussis may cross react with the adenylate cyclase 
produced in the human brain and this has raised douhts about its suitability as a 
vaccine component (Parton, 1998).
B. parapertussis and B. bronchiseptica produce ACT similar to B. pertussis but 
they are antigenically distinct (Hewlett and Gordon, 1988).
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1.7.7. Pertactiii (PRN)
PRN is a surface-associated protein that is produced by thi'ee of the Bordetella 
species. A fonn of pertactin designated as P.69 is produced hy B. pertussis and has 
an apparent molecular weight of 69kDa in SDS-PAGE. B. parapertussis produces 
P.70 and B. bronchiseptica produces P.68 which, although of slightly different 
sizes, are homologous proteins (Li et a l, 1991, 1992).
In vitro studies have demonstrated that eukaryotic cells can bind to purified PRN 
and that like FHA, PRN mediates adhesion by a RGD sequence (Leininger et a l , 
1991). The same study showed that mutants lacking PRN have reduced adherence 
properties but can still adhere which suggests that more than one adhesin is 
required for the binding of bacteria to host cells.
The P.68 protein protects pigs from B. bronchiseptica infection (Kobisch and 
Novotny, 1990) and the P.69 protects mice against aerosol challenge with B. 
pertussis (Shahin et a l, 1990). These experiments and the role of pertactin as an 
adhesin have prompted the inclusion of this protein in some of the new acellular 
vaccines (Willems and Mooi, 1996).
1.7.8. BrkA
Serum resistance is a newly-described virulence factor associated with B. pertussis. 
This locus is encoded by two open reading frames, BrkA and BrkB (Fernandez and 
Weiss, 1994), both of which are needed for semm resistance. BrkB is thought to 
be cytoplasmic and is used to transport BrkA to the outer-membrane. BrkA has
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two RGD sequences and is involved in adherence and invasion, as well as in serum 
resistance.
The importance of Brk was shown by Fernandez and Weiss (1994) who 
demonstrated that a mutant in the Brk locus was more susceptible to serum killing, 
less virulent in mice and displayed less adherence and invasion of HeLa cells. 
Although B. parapertussis and B. bronchiseptica contain brk sequences, the genes 
may be transcriptionally silent because the antigens could not be detected with an 
antibody to BrkA (Fernandez and Weiss, 1994).
1.7.9. Pertussis Toxin (PT)
PT is produced by only one Bordetella species, B. pertussis. It is the most studied 
toxin produced by a member of the Bordetella and, in toxoided fonn, is included in 
all acellular vaccine preparations. The toxin is composed of an A subunit and a B 
subunit (Tamura et a l, 1982). It is the B subunit that binds to cell surfaces and 
facilitates the transport of the A subunit which causes the toxic activity. The A 
subunit has ADP-ribosylating activity which acts upon the G proteins of target 
eukaryotic cells causing alteration in the response of these cells to external stimuli 
(Rappuoli and Pizza, 1991). This can result in a variety of consequences including: 
adhesion to eukaryotic cells (Tuomanen and Weiss, 1985) and macrophages, 
promoting leukocytosis, increased vascular permeability, anaphylaxis (Munoz and 
Bergman, 1977) and histamine sensitisation.
Although B. pertussis is the only member of the Bordetella to produce PT, both B. 
parapertussis and B. bronchiseptica contain transcriptionally silent PT genes
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(Arico and Rappuoli, 1987). The PT gene in these bacteria is not expressed
1.7.10. Tracheal Colonisation Factor (TCF)
This protein is unique to B. pertussis and is found both on the surface of bacterial 
cells and released in the culture supemate. TCF has an RGD binding sequence and 
is suggested to function as an adhesin. This is supported by experiments which 
demonstrated that mutants lacking TCF had a decreased ability to colonise the 
trachea of mice (Finn and Stevens, 1995). TCF has only recently been discovered 
and its role in pathogenesis and immunity associated with B. pertussis is unknown.
1.7.11. Osteotoxin
avium produces this protein to compensate for the lack of virulence factors it 
possesses when compared with other Bordetella species.
because of a defective promoter region. Monack et al. (1989) showed that the I
V
insertion of a functional PT operon into B. parapertussis leads to the synthesis of
'Iactive PT and resulted in an increase in the pathogenic potential of the strain.
However, B. parapertussis can still cause disease despite the absence of PT, which 1|
suggests that PT is not a necessity for causing whooping cough (Linneman and -7
PeiTy, 1977; Heininger et a l, 1994; Wirsing von Konig and Finger, 1994).
This is produced only by B. avium. It is cytotoxic for mammalian cells, including f
ft;
osteogenic and tracheal cells (Gentry-Weeks et al, 1993). It is possible that B. 7ft:
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1.7.12. Piracy of adhesins
■;ïI"
1
The piracy of adhesins phenomenon has been reported by Tuomanaen (1986) on
.studies using B. pertussis. The two main adhesins of B. pertussis, PT and FHA, 
are secreted into the surrounding medium and these were shown to bind to the 
surfaces of other bacteria such as Haemophilus influenzae. Staphylococcus aureus 
and Streptococcus pneumoniae. This entranced the adherence of these bacteria to 
ciliated cells and such an event could contribute to the secondary infections that are 
often associated with B. pertussis infection.
1.8. Adherence
Bordetella species mostly cause lower respiratory tract infections and therefore the 
ability to colonise and produce infection depends upon the production of a variety
of adhesins. By producing adherence factors, such as FHA, PRN and PT, the
Bordetella can adhere to the cilia of the tracheal epithelial cells thereby preventing 
their clearance from the respiratory tract. The adherence to, and subsequent 
colonisation of, ciliated epithelial cells plays a major role in the pathogenicity of 
Bordetella species and as such, a variety of assays has been used to observe the 
interaction of these bacteria with the cells of the host respiratory tract.
1.8.1. Adherence assays
The adhesion of Bordetella species to cells has been obseiwed using many types of
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assays including; tracheal organ culture, ciliated epithelial cells and established cell
7lines. ft
ft.ft
Tracheal organ culture most closely reflects the situation in vivo. Investigation of
ft
the interaction o f B. pertussis with tracheal organ culture has been carried out using
#'hamster (Collier et al, 1977; Muse et al, 1977) and baboon (Funnell and ft/
ft
Robinson, 1993) trachea. Collier et al. (1977) showed that B. pertussis adhered ft
jonly to ciliated cells resulting in damage and ultimately the loss of these cells. The |
ft-non-ciliated cells of the same trachea were uninfected, which demonstrated the
selective attachment of R. pertussis to ciliated cells. Further investigation showed ft|
Ithat B. pertussis mutants deficient in FHA and those deficient in the production of 
fimbriae had reduced adherence to baboon tracheal rings (Funnell and Robinson et Ial, 1993). The use of tracheal rings for investigation into the adherence
ft-
mechanisms of Bordetella allows the study of the interaction between bacteria and 
the ciliated cells of the trachea. However, the systems discussed here do not study ft
the interaction of B. pertussis with the trachea of the host species. Such a system ft
would possibly be more relevant than the interaction with tracheal epithelial cells
ftof a species that does not suffer from a Bordetella infection.
Bordetella species adhere to the ciliated respiratory epithelium (Yokomizo and *f
Shimizu, 1979; Marks et a l, 1980) therefore the use of ciliated respiratory ft
i f t
epithelial cells provides an opportunity to study the interaction of these bacteria /ft
with host cells. A study ofB. bronchiseptica revealed that it attached preferentially '
to the cilia of ciliated epithelial cells (Jaques et ï^/., 1988) and a study of R  pertussis 
revealed that adherence was specific for the ciliary tuft close to the cell body ft|
(Tuomanen and Hendley, 1983). Ciliated respiratory epithelial cells have been
.. .
used to investigate the species specificity of Bordetella (Tuomanen et al, 1983) 
and showed that B. pertussis and B. parapertussis adhered best to human ciliated f
cells whereas B, bronchiseptica adhered best to non-human mammalian cells. B, 
avium has been shown to adhere specifically to turkey ciliated epithelial cells 
(Tuomanen, 1988).
The use of ciliated cells allows study of the interaction of Bordetella with their 
natural target cells. However, these cells do not survive long in tissue culture 
(Tuomanen, 1988). Therefore, non-ciliated cell lines provide an alternative method 
for investigating the adherence of these bacteria.
A variety of cell lines has been used in adherence assays for B. pertussis including;
human buccal epithelial cells (Plotkin and Bemis, 1984), Vero cells (Gorringe et 
al, 1985; Funnell and Robinson, 1993), HeLa cells (Sato et a l, 1981), HEp-2 cells 
(Geuijen, 1996) and WiDr cells (Urisu et a l, 1986). Different mechanisms of 5. 
pertussis adherence have been demonstrated using HeLa, Vero, and WiDr cell 
lines. The adherence of B. pertussis to Vero cells involves FHA, PT and fimbriae 
(Gorringe et al, 1985), whereas, the adherence to HeLa cells utilises FHA and 
fimbriae (Sato et a l, 1981; Redhead, 1985), and the adherence to WiDr cells 
utilises only FHA (Urisu, 1986). Although these cell lines are of use to observe the 
adherence of B. pertussis they are not ciliated and therefore do not reflect the 
situation which occurs in vivo. In addition, none of the cell lines mentioned are 
natural target cells for the Bordetella species so the relevance of using such cell 
lines is both limited and questionable.
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(1994) who used human colon carcinoma Caco-2 and lung carcinoma cells in their 
assays. They reported that a significant proportion of B. bronchiseptica could be 
found free in the cytoplasm of infected cells where they persisted, whereas, B. 
pertussis remained inside vacuoles and the number of viable cells decreased over 
time. Guzman et al. (1994) used mouse dendritic cells to investigate the invasive 
ability of B. bronchiseptica. Using transmission electron microscopy, they 
revealed that B. bronchiseptica grew and replicated intracellulaiy and suggested
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1.9. Invasion
Bordetella species were thought to be non-invasive pathogens (Preston, 1988).
However, there has been a number of reports recently on the invasive potential of S
these species. HeLa cells have been used in a number of studies to demonstrate the "I'
invasive capabilities of B. pertussis and B. parapertussis (Ewanowich et al, 1989;
Lee et al, 1990). Ewanowich et al. (1989) reported the invasive capacities of their 
strains oîB. parapertussis were comparable with those of Salmonella and Shigella, 
which are invasive as part of their disease process. By using cytochalasins B and 
D, which inliibit microfilaments, Ewanowich et al. (1989) indicated that the uptake 
of B. parapertussis is via an endocytic process. The same study showed that 
hyperimmune sera raised against FHA did not inhibit invasion by B. parapertussis, 
therefore, suggesting that FHA is not essential for the invasion of HeLa cells by B. |
parapertussis. Lee et al (1990) suggested that FHA and PRN were both necessary 
for the invasion of B. pertussis in HeLa cells and it is therefore possible that these 
species have slightly different invasion mechanisms. The possibility of different AIinvasion mechanisms by Bordetella species is further supported by Schipper et al.
ythat this may be due to down-regulated products. It has already been |
established that, unlike other Bordetella species, B. bronchiseptica has bvg-
t
downregulated genes that enable its survival outside its natural host environment
(Yuk et a/., 1996). Therefore, it is possible that this process enables its ft
multiplication inside host cells when the other species have yet to be shown to
replicate in such circumstances.
Regardless of the mechanisms employed by Bordetella species to invade cells, the 
ability to invade host cells provides these organisms with a definite suiwival 
advantage and could contribute to a carrier status.
1.10. Interaction with host immune cells
Macrophages are an important part of the host immune system and as such, the 
ability to survive phagocytosis and remain viable within the cell provides a 
bacterium with a significant survival advantage.
Cheers and Gray (1969) were the first to observe that B. pertussis could persist 
intracellularly within murine alveolar macrophages experimentally. Further 
experimental investigations showed that B. pertussis could survive in vitro within 
rabbit alveolar macrophages for 4 h (Saukkonen et a l, 1991) and human T
macrophages for 3 d (Friedman et al., 1992). However, the first report of 
intracellular B. pertussis occurring naturally was by Bromberg et al. (1991) who 
detected B. pertussis within the pulmonary alveolar macrophages of children with 
human immunodeficiency virus infection. B. bronchiseptica has been reported to
I
survive in vitro within murine macrophages (Banemann and Gross, 1997) and
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murine macrophage-like cell lines (Forde et al., 1998).
Using macrophages and polymorphonuclear leucocytes, possible mechanisms 
employed by B. pertussis and B. bronchiseptica for the uptake and survival within 
phagocytes have been suggested. B. pertussis can adhere to macrophages via PT 
and FHA (Reiman et al., 1990; Saukkonen et a l, 1991; van’t Wout et al., 1992). 
PT cames carbohydrate-recognition domains which can mediate attachment of B. 
pertussis to carbohydrates present on the macrophage cell surface (Saukkonen et 
ah, 1991). Reiman et al. (1990) determined that the RGD sequence of the B. 
pertussis adhesin FHA interacts with the integrin CR3 on the macrophage surface. 
Saukkonen et al. (1991) showed that this interaction promoted the phagocytosis of 
B. pertussis into mammalian macrophages. The importance of the presence of 
FHA is demonstrated by Friedman et a l (1992) who found that FHA mutants 
resulted in decreased internalisation within macrophages. Intracellular uptake via 
CR3 does not trigger an oxidative burst (Wright and Silverstein, 1983) and this 
may promote intracelluar survival of B. pertussis within the macrophage. 
Interaction with macrophage CR3 to induce phagocytosis is common among 
intracellular pathogens such as Legionella pneumophila (Payne and Horwitz, 1987) 
and Leishmania donovani (Wilson and Pearson, 1988) therefore this mechanism 
suggests an important role for intracellular persistence during B. pertussis 
infection.
The survival o f B. pertussis within macrophages is suggested to be due to the 
production of AC which increases the intracellular cAMP concentration thereby 
preventing the fusion of the B. /jerto^ï’^ -containing phagosome and the lysosome 
(Masure, 1993). This is supported by evidence that AC mutant strains had a
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decreased ability to enter and survive intracellularly (Friedman et a l, 1992) and |
drug-induced elevation of cAMP in macrophages complemented the survival of
AC mutants (Masure, 1993). The AC-HLY (adenylate cyclase-haemolysin) of B.
pertussis also induces host macrophage apoptosis (Klielef et a l, 1993b; Khelef and
Guiso, 1995) and AC and PT inhibit the oxidative burst of macrophages (Confer |
and Eaton, 1982). This could allow prolonged intracellular survival of the bacteria. I
The production of virulence factors appears to increase the uptake and survival of
I.,B. pertussis within macrophages (Friedman et a l, 1992). This is in contrast with 
the method of macrophage entiy and intracellular suiwival employed by B. 
bronchiseptica. The expression of hyg-activated virulence factors is not necessary 
for the uptake and intracellular survival of B. bronchiseptica. Intracellular uptake 
and survival of B. bronchiseptica within macrophages was found to increase in the 
absence of èvg-dependent virulence factors. Phagosome-lysosome fusion occuned 
when B. bronchiseptica was within the phagosome (Banemann and Gross, 1997).
This is in contrast to B. pertussis which inhibits the fusion of the phagosome and 
lysosome (Steed et a l, 1991; 1992). The fusion would expose B. bronchiseptica to
5.
attack by reactive oxygen metabolites and lysosomal material, yet B. 
bronchiseptica can suiwive within murine macrophages (Banemami and Gross,
1997) suggesting that negatively-regulated virulence factors may contribute to the 
intracellular suiwival. These findings suggest that there may be an intracellular 
phase during B. bronchiseptica and B. pertussis infections.
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1.11. Genetic regulation
The expression of Bordetella virulence factors is regulated by the Bordetella 
virulence gene {bvg) locus which is composed of two genes, bvgA and hvgS. The 
BvgS protein is located in the cytoplasmic membrane and acts as a sensor of 
environmental signals. This passes messages across the membrane to the BvgA 
protein which is found in the cytoplasm (Stibitz and Yang, 1991). BvgA then 
activates the transcription of the virulence factors encoded by the virulence- 
activated genes {vag) and the repression of the virulence-repressed genes {vrg) 
(Weiss et a l, 1983).
BvgAS positively regulates most of the virulence factors presumed to be required 
for the initiation and establislunent of infection including, PT, FHA, ACT, HLT, 
PRN and fimbriae. These are encoded by the vag genes. The motility of B. 
bronchiseptica and B. avium is negatively regulated by the BvgAS system 
(Akerley et a l, 1992; Yuk et a l, 1996) and is encoded by the vrg genes. This 
provides these species with a possible mechanism of survival outwith the host.
1.11.1. Antigenic modulation
Bordetella species have the ability to switch between virulent (Bvg^ *) and avirulent 
(Bvg') phases. This is called antigenic modulation and occurs in response to 
changes in the environment such as low temperatures and the presence of 
modulators such as NaCl, MgSO^ and nicotinic acid (Lacey, 1960). Antigenic 
modulation is freely reversible and affects all of the cells in the population.
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1.11.2. Phase variation
Phase variation also involves the switch from the Bvg^ phase to Bvg' phase, 
however, it is rarely reversible. This occurs when there is frameshift mutation or a 
deletion in the bvgS gene (Stibitz et al., 1989) and arises at a frequency of 1 per 
1 Ohio‘S organisms.
1.12. Vaccines
In 1974-1975 whooping cough vaccine uptake in the UK decreased from around 
80% to 40% because of concern about the possible hannful side effects of
vaccination. The decrease in immunisation of the susceptible population resulted 
in an increase in incidence of whooping cough in 1978-1979 when the next peak of 
the epidemic cycle occun*ed (Noble et a l, 1987).
In general, vaccination programmes against whooping cough have been very 
effective in reducing the incidence of this disease but there ai'e concerns that,
although the current whole-cell vaccines protect against disease, they do not
sprotect against infection (Willems and Mooi, 1996). This can lead to adults with
waning immunity becoming an important reservoir of infection for those who are €
7susceptible (Aoyama et al, 1992). It could also explain why, in many countries :
with high uptake of the vaccine, there are still peaks in the incidence of pertussis 
every 3-4 years (Fine, 1988). It also provides evidence that the whole-cell vaccines 
have not significantly affected the circulation of B. pertussis in the human 
population (Fine and Clarkson, 1987; Grenfell and Anderson, 1989).
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.VWhole-cell vaccines do give good protection against whooping cough but the |
concerns about the safety of these vaccines and their reactogenicity prompted the
search for safer vaccines (Parton, 1998). The extensive knowledge of pertussis
antigens enabled the production of acellular vaccines which contain what are
considered to be the major virulence factors of pertussis involved in infection: f
pertussis toxin in toxoided foim (PTd), filamentous haemagglutinin (FHA),
Îfimbriae and pertactin (PRN) (Willems and Mooi, 1996). Acellular vaccines have 
been used in Japan since 1981 and have shown to be effective and resulted in a
¥lower rate of side effects compared to whole-cell vaccines (Kimura and Kuno-
Sakai, 1990). However, as with the whole-cell vaccines, the acellular vaccines 
appear to protect only against the disease and not infection, which still leaves the 
problem of an adult reseiwoir of infection (Aoyama et al, 1993). This finding is 
supported by one of the first field trials of two acellular vaccines, during 1986- 
1987 in Sweden. The vaccines used were a monocomponent PTd vaccine and a 
two-component PTd and FHA vaccine (Ad Hoc Group, 1988). The reactogenicity f
of these vaccines was low but the efficacy was less than would have been expected Ifor whole cell vaccines. However, both these vaccines gave reasonable protection 7
1against the disease and provide a safer alternative to the whole-cell vaccines.
vT'"A-
Further testing of other acellular vaccine formulations has supported the earlier Ifindings that they have a reduced reactogenicity and are safer than whole-cell
f-
vaccines. These vaccine trials have shown that the most efficacious acellular 
vaccines contained components such as FHA, PRN or agglutinogens (fimbriae) in
addition to PTd (Plotkin and Cadoz, 1997). 7■¥7:Although the monocomponent PTd vaccines did give good protection against B.
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pertussis, these vaccines would not protect against B. parapertussis infections 
because B. parapertussis does not produce PTd. B. parapertussis also causes 
whooping cough albeit usually less severe and less frequently than B. pertussis but, 
it still has the potential to cause a severe infection. Therefore, more antigens than 
PTd alone need to be components of an acellular vaccine if it is to be completely 
successful against whooping cough. Studies have shown a lack of cross protection 
between B. pertussis and B. parapertussis due to subtle differences in their 
antigens (Klielef et a l, 1993a). However, a recent vaccine trial comparing a 
whole-cell vaccine to an acellular vaccine containing PT, FHA, PRN and fimbriae 
demonstrated that the acellular vaccine provided better protection against B. 
parapertussis infection (Heininger et al, 1998).
1.13. Respiratory tract
1.13.1. Structure of the respiratory tract
The respiratory tract of all mammals includes the nasal cavities, which extend 
tluough the nasophaiynx and orophaiynx to the trachea. The trachea divides into 
two bronchi that extend into the lungs. Inside the lungs, the bronchi are subdivided 
into bronchioles, which branch into the alveoli.
Several mechanisms protect the respiratory tract from infection. The nasal 
turbinates have ciliated cells and a mucus lining. Bacteria which become trapped 
in the mucus are expelled from the nasal cavity by ciliary activity and swallowing 
or by sneezing. The same protection mechanism exists in the trachea, which is 
lined with ciliated epithelial cells. Here, the coughing reflex may help to expel any
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trapped bacteria. Respiratory secretions contain many factors which have either 
antimicrobial properties or prevent the establishment of bacterial infection in the 
respiratory tract. These include lung surfactant, lysozyme, lactoferrin and 
secretory IgA. If these defence mechanisms are evaded, the bacteria finally enter 
the alveoli where they are ingested by alveolar macrophages. Once ingested, 
bacteria are either killed or persist intracellulary.
1.13.2. Composition of respiratory fluids
Respiratory tract secretions from humans contain approximately 95% water, 
proteins and glycoproteins (2-3%), lipids (1%) and minerals (1%) (Matthews et ai, 
1963). There are few reports on the contents of respiratory secretions and those 
that are available present different amounts. The amounts given here are for 
human secretions.
The protein content of respiratory secretions has been reported to be between 4.2 
mg ml ' and 0.068 mg ml ' (Low et aL, 1978; Kaliner, 1991). Albumin is the major 
serum protein of the secretions and is reported to be present in respiratoiy 
secretions at a concentration of 1.42 mg mb' (Reynolds and Newball, 1974) and in 
TBW, which are more dilute, at 17.4 pg mb' (Low et a l, 1978). Brogan et al 
(1975) reported the concentration of lysozyme to be 0.16-0.7 mg ml ' and 
lactoferrin to be 0.05-0.5 mg mb'. Other protein constituents include 
immunoglobulins. Reynolds and Newball (1974) measured the IgA concentration 
at 0.91 mg mb', IgG 0.17 mg mb' and IgE 73.2 ng mb'.
The carbohydrate concentration of respiratory secretions has been reported to be
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9.5Img mb' (Matthews et a l, 1963) and 0.008 mg mb’ in TBW (Low et a l, 1978). 
Matthews et al (1963) measured the total lipid concentration of respiratoiy 
secretions to be 8.4 mg mb'. The lipid content of human TBW was measured in 
three parts by Low et al (1978). Non-polar lipids were present at a concentration 
of 77.8 pg mb’, polar lipids at 44.1 pg mb’ and phospholipid at 1.09 pg mb’. The 
same study found the phospholipid of human TBW to be 83.8% 
phosphatidylcholine which is the lung surfactant providing surface tension in the 
lung to prevent collapse. The amino acid content of human respiratory secretions 
has been reported by Potter et a l (1967) to be 31.8 mM. The analysis of human 
respiratory secretions by Matthews et al (1963) determined the chloride 
concentration to be 1.62 mg mb’, sodium 1.65 mg mb’, potassium 0.132 mg mb’ 
and calcium 0.062 mg mb’.
Low et a l (1978) also measured the different types of immune cells in human 
TBW. Of these, 94,8% were macrophages, 3.5% were lymphocytes and 
polymorphonuclear leukocytes accounted for 1.7%.
The composition of respiratory secretions is known to change when the subject is 
in the disease state. Matthews et a l  (1963) reported that patients with cystic 
fibrosis had higher concentrations of protein, lipid and DNA in respiratory 
secretions when compared with healthy people. It has also been reported that the 
amino acid content of washings increases with the severity of infection (Potter et 
al, 1967).
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1.14. Aims of Thesis
I■é-:
■;l=Previous studies have shown that ovine and human isolates of B. parapertussis are 
genetically distinct and that variation exists within isolates from the same host 
species (Porter et a l, 1994 and 1996; van der Zee et a l, 1996). However, there has 
been little investigation into the virulence capabilities of these isolates. The aims 
of this study were to compare the virulence-related properties of ovine and human 
B. parapertussis isolates and to determine if there was any host specificity.
The survival of B. parapertussis in the respiratory tract requires the ability to 
adhere to the respiratory mucosa and to grow in the respiratory fluid. In addition,
B. parapertussis also encounters the alveolar macrophages of the respiratoiy tract 
and the ability to remain viable within these cells would provide B. parapertussis 
with a significant survival advantage. The aim, therefore, was to study these
factors using in vitro assays designed to demonstrate any host specificity of ovine 
and human B. parapertussis.
Porter et al. (1995c) showed that ovine and human B. parapertussis reacted 
differently to monoclonal antibodies specific for LPS. This may be reflected by 
different LPS patterns on PAGE and this was also investigated.
Using multilocus enzyme electrophoresis. Porter et al. (1994) showed that ovine B. 
parapertussis isolates could be separated into two electrophoretic types. A 
representative from each of these groups (isolates HI and K2) and two human 
isolates (B285 and NCTC 10520) were used tlii'oughout this study.
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CHAPTER 2
MATERIALS AND METHODS
2.1. General methods
2.1,1. Bacteria and culture conditions
Throughout this work, the following bacterial stiains were used. 
Table 2.1. List of bacterial isolates.
Strains Source Reference
B. parapertussis
H1,K2, C, J1 
NZ928
Ovine lung 
Ovine lung
Moredun Research Institute (Porter et al, 
1994)
Prof. B. Manktelow, Massey University, 
New Zealand
B285,B268,B271 Human Dr. A. van der Zee, National Institute for 
Public Health and Enviromnental 
Protection, The Netherlands
NCTC 10520, NCTC 5952 Human Dr. R. Parton, University of Glasgow
P. haemolytica
A2 (124/92) Ovine Moredun Research Institute
Corynebacterium bovis Moredun Research Institute
All strains were stored on glass beads using the CRYOBANK system (Mast 
Diagnostics) where tubes containing glass beads and a hypertonic cryopreservative 
solution were inoculated with bacterial cultures then stored at -70°C. When 
required, the strains were recovered horn storage and plated onto Bordet-Gengou
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agar (Difco) supplemented with 15% sheep blood and incubated at 37°C for 2-3 
days in a moist atmosphere. Further culture of B. parapertussis was either in 
nutrient broth (Difco) or cyclodextrin liquid medium (Imaizumi e/ a/., 1983). P. 
haemolytica was grown overnight at 37'^C on agar containing 5% sheep blood and
C. bovis was grown on 5% sheep blood agar for 2 days at 37°C.
2.1.2. Haemagglutination assay
This was based on a haemagglutination assay developed by Ishikawa and Isayama 
(1988). Briefly, bacteria were resuspended in phosphate-buffered saline (PBS, pH 
7.4) and standardised to an Aggo ”  10. Serial doubling dilutions were made in U- 
well microtitre plates, each well containing 50 pi of a bacterial suspension. 50 pi 
of 1% sheep blood in PBS was added to each well. The plates were incubated at 
37°C for 1 h. The end point was taken as the first dilution where a button of red 
blood cells appeared at the bottom of a well. The greater the dilution at the end 
point, the more filamentous haemagglutinin produced.
2.2. Growth studies
2.2.1. Collection of lung washings
Ovine tracheobronchial washings (TBW) were collected and prepared as described 
by Sutherland (1989). Briefly, the lungs and tracheas were excised from sheep and 
washed with 500 ml PBS. The lungs were massaged and the fluid poured into a
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container tlirough a gauze-covered filter. This was repeated once and a total 
volume of approximately 500 ml was recovered. The washings were centrifuged at 
500 X g to pellet any cellular debris and the supernatant collected. The supemate 
was further centrifuged at 2000 x g for 30 min to pellet any bacteria present then 
filtered through a 0.45 pm filter. The TBW were plated onto blood agar overnight 
at 37°C to check for sterility then aliquoted and stored at -70°C.
2.2.2. Growth experiments
The method was based on that used by Porter and Wardlaw (1994). Bacteria were 
recovered from storage at -70°C and grown for 3 days on Bordet-Gengou agar at 
37°C. The cultures were resuspended in PBS and the bacterial suspensions were 
standardised to A540 ^  0.45 which gave a concentration of approximately 1 x 10® 
cfu mb'. The bacteria were pelleted at 11600 x g for 10 min then washed thi*ee 
times and resuspended in PBS. 25 pi of bacterial suspension was added to 975 pi 
of test fluid to give a bacterial concentration of approximately 1 x lO'* cfu mb'. The 
number of viable bacteria was confirmed by plate counts on blood agar. The :
inoculated fluids were incubated for 72 h at 37°C on a shaker at 135 rpm. Counts 
of viable bacteria were taken every 24 h by plating dilutions onto blood agar.
2.2.3. Purification of IgG
IgG was purified from TBW 5 using a protein G cohmm (MAb Trap GII,
Pharmacia) according to the manufacturer’s instructions. Briefly, the column was 
washed with 5ml of distilled water to remove the ethanol preservative. From this
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point, all fractions were collected in volumes of 1ml and the absorbance of each 
fraction was measured at 280 nm. The column was equilibrated with 4ml of the 
supplied binding buffer then 1ml of the sample TBW was applied. The column 
was then washed with 7-10 ml of binding buffer until no absorbance was measured 
in the effluent. This was followed by elution with 3-5 ml of the provided elution 
buffer. At this point, the IgG was eluted from the column and the column was 
reconditioned with 5 ml of binding buffer.
The concentration of IgG present in TBW 5 and the amount purified was analysed 
in the Biochemistry Department, MRI by J. Small.
2.2.4. SDS-PAGE
Samples were dissolved in sample buffer (2% w/v sodium dodecyl sulphate (SDS),
5% w/v glycerol, 2 % v/v 2-mercap to ethanol, 0.002% bromophenol blue and 
125mM Tris/HCl, pH 6 .8) and heated in a boiling water bath for 5 min. Samples 
were then resolved by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) on a 
10% (w/v) acrylamide gel using the discontinuous buffer system of Laemmli 
(1970). Proteins were detected by Coomassie blue and/or silver staining. (All 
reagents for SDS-PAGE are detailed in Appendix I).
2.2.5. Coomassie blue staining of SDS-PAGE gels for protein
Coomassie blue stain was added to a gel and shaken for a minimum of 2 h at room 
temperature. The gel was then placed in destaining solution and shaken at room
i-
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temperature until the required destaining was achieved.
2.2.6. Silver staining of SDS-PAGE gels for proteins
Silver staining of gels was achieved using the method of Monisey (1981).
Gels were incubated for 30 min in 50% v/v methanol and 10% v/v acetic acid 
followed by incubation in 5% v/v methanol and 7% v/v acetic acid for 30 min and 
10% v/v glutaraldehyde for a further 30 min. Following an overnight wash in 
distilled water the gel was added to 0.005 mg mU dithiotlrreitol for 30 min then 
incubated in 0.1% w/v silver nitrate for 30 min and rinsed once in a small amount 
of distilled water. The gel was developed in 100 ml of 3% sodium carbonate 
solution with 500 pi of 37% formaldehyde and the reaction stopped by the addition 
of 7 ml of 2.3 M citric acid.
2.2.7. Western blotting for proteins
SDS-PAGE gels were electroblotted onto nitrocellulose (Schleicher & Schuell) by 
the method of Towbin et al. (1979). Nitrocellulose was blocked using 10 mg mb' 
BSA in blot wash buffer (BWB) for 1 h at room temperature with gentle agitation 
then washed tliree times in BWB. For detection, the nitrocellulose was incubated 
at room temperature for 1 h with a test fluid then washed as described above. 
Nitrocellulose was then incubated for Ih at room temperature with horseradish- 
peroxidase conjugated to donkey anti-sheep IgG (Scottish Antibody Production 
Unit) and again washed in BWB. Substrate colour development was earned out at
48
room temperature in 100 mM Tris pH 7.0, 0.5 mg mb' diaminobenzidine and 2 pi 
mb' of 30% hydrogen peroxide. The reaction was teiminated by the addition of 
water. (All reagents detailed in Appendix I).
2.2.8. Analysis of TBW
Analysis of TBW was carried out in the Biochemistry Department, MRI by J.
Small.
Albumin, calcium, cholesterol, glucose, lipase, magnesium, phosphoms and total 
protein were analysed using commercial kits adapted for a Monarch 2000 
centrifugal analyser. Sodium, potassium and chloride were measured using an ion- 
specific electrode on a Monarch 2000 centrifugal analyser. IgG was estimated 
turbidmetrically using the method of Seneviratne and Moores (1980) which was 
adapted to a Monarch 2000 centrifugal analyser. The iron present in TBW was 
analysed using a PU9200X atomic absorption spectrophotometer.
2.2.9. API analysis
API ZYM (bioMerieux) was used to measure the production of enzymes by the 
different B. parapertussis isolates. Bacterial cultures were suspended in sterile 
distilled water to give a suspension with turbidity between a McFarland No 5 and 
No 6 standard (bioMerieux). The API ZYM strips were inoculated with the 
different bacterial suspensions and incubated for 4 hours at 37°C. After 
incubation, ZYM A and ZYM B reagents were added to each strip and a colour
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reaction developed. The colour intensity was proportional to the amount of
enzyme produced. This system allowed the measurement of the following 
enzymes: alkaline phosphatase, esterase, esterase lipase, lipase, leucine
■arylamidase, valine arylamidase, cystine arylamidase, trypsin, chymotrypsin, acid 
phosphatase, naphthol-ASBI-phosphohydrolase, a  galactosidase, p galactosidase, ^
p glucoronidase, a  glucosidase, p glucosidase, N-acetyl-p glucosaminidase, a 
mannosidase, a  fucosidase.
2.3. Bacterial adherence
2.3.1. Adherence assay using cell lines
The cells were obtained from the Tissue Culture Department, MRI. Foetal lamb 
turbinate cells, foetal lamb lung cells and human foetal lung cells (MRC-5) were 
provided in 8 -well Pennanox chamber slides (Lab-Tek) at a concentration of 1 x 
10^  cells ml"'. The foetal lamb cells were grown in 199 medium (Difco) 
supplemented with 15 % tiyptose phosphate broth and 0.65% sodium bicarbonate.
Before use, 10% heat-inactivated foetal bovine serum (FBS) and 1% glutamine 7:
was added to the medium (199S). The MRC-5 cells were grown in Eagle’s 
Minimum Essential Medium (EMEM) supplemented with 1% basic amino acid 
solution and 10% FBS. Bacteria were taken from 72 h cyclodextrin liquid cultures.
The bacteria were pelleted at 11600 x g for 10 min then washed tlmee times in 
199S. The bacterial suspensions were then standardised to give an infoctivity ratio I
of approximately 30 bacteria per cell. The cells were washed three times with 
Hank’s balanced salt solution (Hanks) and 250 pi of a bacterial suspension was 
added to each well. The slides were incubated for 1 h at 37°C in 5% CO2. After
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incubation, the slides were washed three times in Hanks, to remove non-adherent 
bacteria, then fixed with 1% formol saline for 30 min. The slides were then Gram- 
stained and the number of bacteria adhering to 100  cells was counted.
2.3.2. Adherence assay using tracheal organ culture
This was based on the method described by Funnell and Robinson (1993). Trachea 
were excised h'om sheep and stored in Hanks solution during transportation. The 
trachea were then cut into rings and placed in wells of a 6 -well tissue culture dish 
(Life Technologies) where they were held in place with molten 1.5% w/v 
bacteriological agar (Difco). A bacterial suspension of approximately 3x10^ cfu 
mb' in EMEM supplemented with 10% FBS and 1% HEPES was added to the 
inside of each ring. The rings were then incubated for 1 hour at 37^C in 5% COg. 
The rings were washed thi*ee times in Hanks and the inside of the rings scraped 
using a sterile scalpel blade and this was resuspended in EMEM. Serial dilutions 
of this were plated onto sheep blood agar to determine the number of bacteria that 
had adhered to the tracheal rings.
B. parapertussis HI culture supernate was obtained fi*om cultures in cyclodextrin 
liquid medium that had grown to a concentration of approximately 1x10® cfu mb'. 
The cultures were centrifuged at 11600 x g for 5 min to pellet the bacterial cells 
and the supemate was filtered tlirough a 0.45 pm filter.
2.4. Invasion
The ability of different isolates of B. parapertussis to invade cell lines was
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investigated using a method based on that described by Ewanowich et a l (1989). 
The cell lines and conditions were the same as for the adherence assay using cell 
lines except that the bacteria and cells were incubated together for 5 h at 37°C in 
5% CO2. The cells were washed tlmee times in Hanks then incubated in 100 pg 
mb' gentamicin in 199S medium for 90 min at 37°C in 5% COj. Following a 
further washing step, the cells were lysed with 1% saponin in PBS containing 2% 
FBS. From this, serial dilutions of the lysate were plated onto sheep blood agar to 
determine the number of bacteria that had invaded the cell lines and remained 
viable.
2.5. Macrophage interaction
2.5.1. Collection and culture of alveolar macrophages
Collection was as previously described in collection of lung washings but instead 
of discarding the pelleted cells they were kept. The remaining steps were as 
described by Sutherland (1989). If contaminating red blood cells were present they 
were removed by resuspending the pellet in 10 ml of Ix PBS. Double-distilled 
water (20 ml) was added and mixed quickly for 30 sec. This was followed by the 
addition of lOx PBS (2 ml). The suspension was then centrifuged at 800 x g for 5 
min and the supernate, containing the cells, was removed. Cells were washed in 
Hanks balanced salt solution and resuspended in RPMI 1640 supplemented with 
150 lU mb' nystatin, 50 lU mb' penicillin and 50 pg mb' streptomycin. Viability 
was determined with nigrosin (0 .1%) and macrophages were counted using an 
improved Neubauer haemocytometer. Macrophage concentration was adjusted to
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1x10*' cells mb' and 100 pi added to 96-well tissue-culture plates. These were 
incubated at 2>TC in 5% COj until required.
2.5.2. Phagocytosis assay
This was based on the method described by M'^Neil et al. (1994). Bacterial 
cultures were adjusted to approximately 3x10^ cfu mb', washed and resuspended in 
RPMI without antibiotics. The macrophage cultures in 96-well tissue-culture 
plates were washed three times in Hanks, the bacteria added and incubated at 37°C. 
After incubation for 90 min, macrophages were washed three times in Hanks then 
RPMI containing 100 pg mb' of gentamicin was added to kill extracellular bacteria 
and the plates were incubated for a further 60 minutes. The cells were then washed 
tliree times with Hanks and macrophages were lysed by the addition of lOOpl of 
1% saponin in PBS containing 2% FBS. From this lysate, serial dilutions were 
plated onto sheep blood agar to detemiine the numbers of surviving intracellular 
bacteria.
For opsonisation, washed bacteria were incubated in antiserum at room 
temperature for 15 min.
2.5.3. Adherence to macrophages
This was based on the method described by Hondalus and Mosser (1994). 
Macrophages (1x10^ mb') and bacteria (3x10^ cfu mb') were prepared as above 
except that the macrophage culture was carried out in 8 -chamber Permanox slides
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(Lab-Tek). Each bacterial isolate was added to one chamber of a slide. After 
incubation for 90 min, the slides were washed and 3% foi*maldehyde was added to 
each chamber. The slides were incubated for 30 min and washed with Hanks then 
Gram-stained and left to dry. Using lOOOx magnification and oil-immersion, the 
number of bacteria associated with 100  macrophages was counted.
2.5.4. Intracellular bacteria within macrophages
The assay was performed as above except that following the 90 min incubation, the 
slides were washed, then 100% methanol was added to each chamber. The number 
of bacteria associated with 100 macrophages was counted. Methanol peimeabilises 
the macrophage cell membrane allowing the visualisation of both extracellular and 
intracellular bacteria. In order to calculate the number of intracellular bacteria 
within 100  macrophages, the number of bacteria adhering to 100  macrophages (as 
described in 2.5.3) was subtracted from the number of bacteria associated with 100 
macrophages using methanol fixation.
2.5.5. Intracellular survival of bacteria in macrophages
The same methods were used as for the phagocytosis assay and for calculation of 
the number of adherent and intracellular bacteria except, after the addition of 
gentamicin for 60 minutes, the cells were washed three times in Hanks and 10 pg 
mU polymyxin in RPMI was added to each well/chamber. The plates/slides were 
then incubated for a total of either 24h or 48h. The cells were then washed tliree
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times with Hanks and the cells on 96-well plates were lysed as before and dilutions 
plated onto blood agar. The cells on chamber slides were fixed and stained as 
before.
2.6. Lipopolysaccharide (LPS) analysis
2.6.1. LPS preparation
Bacterial LPS was prepai'ed using the micro phenol method of Fomsgaard et al. 
(1993). Bacteria were removed from Bordet-Gengou agar and resuspended in PBS 
then added to 2 ml of either nutrient broth or cyclodextrin liquid medium to give a 
final concentration of approximately 1x10^ cfu m l''. The broths were incubated 
for 3 days at 37°C. 1.5 ml of the cultures was transfen'ed to an Eppendorf tube. 
The cells were pelleted at 11600 x g, washed twice and resuspended in 500 pi of 
pyrogen-free water. Aqueous phenol (500 pi of 90% v/v) was added and the tube 
vortexed for 10 sec followed by placement in a water bath at 70°C for 10 min with 
vortexing at inteiwals. The tube was immediately placed on ice for a minimum of 2 
min and centrifuged at 2900 x g for 4 min at room temperature. The upper clear 
layer was removed carefully with a pastette and stored at -20°C.
2.6.2. PAGE for LPS
Using the method of Hancock and Poxton (1988), LPS samples were boiled in 
sample buffer (0.125M Tris/HCl pH 6 .8 , 4% SDS, 20% glycerol, 2% 2 -
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mercaptoethanol and 0.002% bromophenol blue) for 5 min. The samples were 
resolved using 12% or 14% (w/v) gels using the discontinuous buffer system of 
Laemmli (1970). LPS was visualised using silver stain (see below). (Reagents for 
LPS PAGE detailed in Appendix I).
2.6.3. LPS silver stain
Using the method of Hancock and Poxton (1988), the gel was placed into a 
container with 200 ml of 25% v/v propan-2-ol and 7% v/v acetic acid overnight. 
The solution was discarded and replaced with 1.05 g of periodic acid in 150 ml of 
distilled water and 4 ml of the above solution for 5 min. The gel was then washed 
in at least 4 changes of distilled water for over 4 h. This was followed by 
incubation for 15 min in a solution consisting of 21 ml of 0.36% sodium 
hydroxide, 1.4 ml of ammonia solution (0.88 SG), 4 ml of 19.4% silver nitrate 
solution (which had been added slowly) topped up to 100ml with water. The gel 
was again washed in 4 changes of distilled water for over 40 min. The water was 
replaced with a freshly prepared solution of 0.005% citric acid in 0.019% 
fonnaldehyde and left to develop. When the desired staining was reached, the gel 
was repeatedly rinsed in large volumes of distilled water.
2.6.4. Western blotting of LPS
LPS PAGE gels were electroblotted onto nitrocellulose (Schleicher & Schuell) by 
the method of Hancock and Poxton (1988). After blotting overnight at 10-12 V,
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the nitrocellulose was washed in Tris-buffered saline (TBS) for 10 min then
blocked in 3% w/v gelatin in TBS for 30 min at room temperature. The , i
nitrocellulose was incubated for 3 h with antisemm diluted in TBS followed by a
brief rinse in distilled water and washed for two 10 min periods in Tween Tris-
buffered saline (TTBS). The nitrocellulose was then incubated with horse-radish
peroxidase conjugated to goat anti-rabbit (Bio-Rad) or donkey anti-sheep (Sigma)
IgG diluted to a working concentration in 1% gelatin in TBS. Following a final 
washing step, the nitrocellulose was developed in 100 inM Tris pH 7.0, 0.5 mg mb' 
diaminobenzidine and 2 pi ml'  ^ of 30% v/v hydrogen peroxide. The reaction was 
terminated by the addition of water. (Reagents for western blotting of LPS PAGE 
are detailed in Appendix I)
2.7. Bactericidal assay
Bactericidal assays were carried out based on the method of Sutherland (1988), as
:adapted by M. Maley (personal communication). The assays were perfomied in 
flat-bottomed 96-well microtitre plates (Life Technologies). Bacteria were 
removed from Bordet-Gengou agar and resuspended in PBS to give a concentration 
of approximately 1 x 10  ^cfu ml '. 10 pi amounts of antiserum (heat inactivated at 
56°C for 30 min) and 50 pi of bacterial cell suspension were incubated together in 
triplicate wells for 15 min at room temperature. 40 pi of SPF lamb seram was 
added to each well as a source of complement. The plates were sealed and
suspension + 50 pi of PBS, to observe the effect of the diluent alone; 50 pi of
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incubated at 37°C for 0 and 45 min. The controls used were: 50 pi of bacterial
bacterial suspension + 10 pi of PBS + 40 pi of complement, to see the effect of the 
complement alone; 50 pi of bacterial suspension + 10 pi of antiserum + 40 pi of 
heat inactivated complement source, to observe the effect of antibody in the 
absence of complement. After incubation, 10 pi from each well was removed and 
inoculated onto sheep blood agar plates, which were incubated at 37°C for 3 days. 
The percentage of bacterial inoculum killed (%K) in each suspension was 
calculated using the following formula:
%K =1- (mean cfu ml * at T^/mean cfu ml'* at T J x 100.
2.8. Statistical analysis
Results were analysed for statistical significance using the Mann-Wlritney test and 
repeated measures of analysis of variance (where mentioned).
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CHAPTER 3 
GROWTH OF OVINE AND HUMAN BORDETELLA PARAPERTUSSIS IN 
OVINE TRACHEOBRONCHIAL WASHINGS (TBW). 
3.1. Introduction
B. parapertussis is a respiratory tract pathogen of both humans and sheep. 
Cullinane et al. (1987) and Porter et a l (1994) isolated this bacterium from the 
tracheobronchial washings (TBW) of both lambs and adult sheep. TBW are 
dilutions of the fluids that bathe the respiratory mucosae and therefore the fluids in 
which B. parapertussis grows in vivo. The isolation of B. parapertussis from two 
different host species suggests a potential for transfer between humans and sheep. 
If this is the case, then B. parapertussis should grow in both human and ovine 
TBW regardless of which species the bacterium was isolated fr'om. This study 
monitored the growth of ovine and human isolates of B. parapertussis in TBW 
fr'om 5 different sheep to detennine if there was any host-specificity of the different 
isolates. Nutrient broth was used as a positive control and PBS (a non-nutrient 
fluid) was the negative control.
3.2. Materials and methods
Ovine TBW were used to monitor the growth of ovine and human B. 
parapertussis. The methods used for the collection of TBW, growth studies, IgG
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purification, SDS-PAGE, Western blotting, TBW analysis and API tests are 
detailed in section 2 .2
3.3. Growth in ovine TBW monitored by viable counts
B. parapertussis ovine isolates (HI and K2) and human isolates (NCTC 10520 and 
B285) were inoculated into ovine TBW and incubated for 72 h at 37°C. Samples 
were taken eveiy 24 h and plated onto blood agar to determine the number of 
viable bacteria. The growth of the different B. parapertussis isolates in the various 
fluids is represented in Fig. 3.1-3.7.
TBW 1 (Fig. 3.1) and 2 (Fig. 3.2) demonstrated little difference between the 
growth of ovine and human B. parapertussis isolates. The number of viable ovine 
B. parapertussis remained approximately the same as at the time of inoculation. 
This was also the case for the human isolates tested in TBW 2. In TBW 1, the 
number of viable human B. parapertussis cells declined over 72 h by one log unit. 
With TBW 3, 4 and 5 (Fig, 3.3-3.5), there was a steady increase in the number of 
ovine B. parapertussis and a decrease in the number of viable human B. 
parapertussis. The human isolates in TBW 3 declined in numbers in the first 24 h 
then slowly increased. The human strain B285 died in both TBW 4 and 5. NCTC 
10520 died in TBW 5 and decreased in viable numbers in the initial 24 h in TBW 4 
followed by a slow increase in numbers. In contrast, the ovine B. parapertussis 
grew slightly in TBW 4 whereas better growth was demonstrated in TBW 3 and 5. 
All the isolates grew in nutrient broth (Fig. 3.6). However, the ovine strains had a 
greater rate of growth than the human strains. PBS did not support the growth of
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Fig. 3.1. Growth of ovine (HI and K2) and human (B285 and NCTC 10520) B. 
parapertussis in ovine TBW 1 over 72 h at 37°C.
Fig. 3.2. Growth of ovine (HI and K2) and human (B285 and NCTC 10520) B. 
parapertussis in ovine TBW 2 over 72 h at 37°C.
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Fig. 3.3. Growth of ovine (HI and K2) and human (B285 and NCTC 10520) B. 
parapertussis in ovine TBW 3 over 72 h at 37°C.
Fig. 3.4. Growth of ovine (HI and K2) and human (B285 and NCTC 10520) B. 
parapertussis in ovine TBW 4 over 72 h at 37°C.
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Fig. 3.5. Growth of ovine (HI and K2) and human (B285 and NCTC 10520) B. 
parapertussis in ovine TBW 5 over 72 h at 37°C.
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Fig. 3.6. Growth of ovine (HI and K2) and human (B285 and NCTC 10520) B. 
parapertussis in nutrient broth over 72 h at 37°C.
Fig. 3.7. Decline of viable ovine (HI and K2) and human (B285 and NCTC 10520) 
B. parapertussis in PBS over 72 h at 37°C.
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any of the B, parapertussis isolates tested (Fig. 3.7). All of the isolates
demonstrated a slow decline in viable numbers over 72 h.
3.4. Statistical analysis of growth of B, parapertussis.
The Mami-Whitney test was used to determine if the growth of human B. 
parapertussis at each time point was significantly different from the growth of 
ovine B. parapertussis.
Table 3.1. Significance of comparison of human vs. ovine B. parapertussis gi'owth 
in various fluids at each time point using the Mann-Whitney test.
Significance of difference between ovine and 
human B. parapertussis
Growth fluid 24 h 48 h 72 h
TBWl 0.006 0.003 0.002
TBW 2 0.13 * 0.001 0.001
TBW 3 0.0005 0.0007 0.0008
TBW 4 0.0003 0.0006 0.0006
TBW 5 0.0007 0.0003 0.0003
NB <0.0001 <0.0001 <0.0001
PBS <0.0001 <0.0001 0.04
This test confirmed that, in all but one comparison (*), the growth of the two ovine 
B. parapertussis isolates was significantly greater than that of the two human 
isolates.
Repeated measures of analysis of variance were used to determine if the overall 
growth of human B. parapertussis in each of the fluids tested was significantly 
lower than the growth of ovine B. parapertussis.
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Table 3.2. Significance of the comparison of ovine and human B. parapertussis 
growth in fluids using repeated measures analysis of variance.
Growth fluid Significant difference between 
ovine and human isolates
TBW 1 <0.001
TBW 2 0.001
TBW 3 <0.001
TBW 4 <0.001
TBW 5 <0.001
NB <0.001
PBS <0.001
Using repeated measures of analysis of variance, it was found that there was a 
statistically significant difference between the smwival of ovine and human B. 
parapertussis in all TBW, nutrient broth and PBS.
3.5. Analysis of TBW
The 5 TBW were analysed for the presence of various nutrients and proteins. The 
results are presented in Table 3.3.
There was little difference in the concentration of components tested for between 
all the TBW. The most notable exception was TBW 5 which contained the highest 
concentration of most substances tested for, particularly total protein, magnesium, 
potassium, but it contained the lowest amount of glucose.
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Table 3.3 Analysis of ovine TBW for potential nutrients (results in mmol 1"' unless 
stated).
Concentration of components in:
Component TBW 1 TBW 2 TBW 3 TBW 4 TBW 5 PBS
Total Protein (mg in f) 1.21 0.76 1.26 0.58 1.76 ND
IgG (mg ml ') 0.42 0.43 0.83 0.40 0.98 ND
Albumin (mg m f  ) 0.33 0.30 0.40 0.18 0.68 ND
Cholesterol 0.15 0.12 0.19 0.14 0.16 ND
Glucose 0.14 0.05 0.14 0.07 0.02 ND
Calcium 0.20 0.11 0.13 0.08 0.25 1.05
Chloride 140 141 137 139 141 124
Iron (jiinol f  ) 5.00 5.30 5.80 5.90 6.00 ND
Magnesium 0.13 0.08 0.10 0.08 0.26 ND
Phosphorus 8.87 8.74 8.73 8.55 8.82 7.97
Potassium 5.03 4.73 4.78 4.69 R02 4.05
Sodium 157 158 155 156 156 148
ND -  not detectable.
3.6. Further analysis of TBW 5
The death of human isolates and growth of ovine isolates in TBW 5 revealed a 
difference between ovine and human B. parapertussis. It is possible that IgG was 
responsible for the death of the human isolates. IgG was purified from TBW 5 
using a protein G column. TBW 5 was applied to the column where the IgG bound 
to protein G. The fractions collected contained TBW 5 minus IgG. During the 
elution step, purified IgG was collected.
Some of the hactions collected were run on SDS-PAGE and visualised using a 
silver stain to determine which fractions contained IgG. Fig. 3.8 clearly shows that 
IgG is purified using this column. Lanes 6-9 show the presence of both a heavy 
(approximately 55 kDa) and a light (approximately 25kDa) chain of IgG whereas 
lanes 2-5 do not contain IgG. However, the amount of IgG in the 1 ml sample
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Fig. 3.8. IgG purified from TBW 5 visualised using silver stain. Lane order: (lane 
1) High molecular weight markers, (lane 2-4) TBW 5 - IgG (fractions 4-6), (lanes 
5-9) purified IgG (fractions 10-14).
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applied to the column is eluted over a number of fractions therefore diluting the 
concentration of the IgG present in TBW 5.
TBW 5 and the fractions which gave the highest absorbance readings at Aggg during h
-
the application of the sample (TBW 5 -  IgG) and elution of IgG were analysed for 
the presence or absence of IgG.
The concentration of IgG present in TBW 5 was 0.98 mg ml"' whereas IgG purified 
from TBW 5 (using the fraction which gave the highest absorbance reading) 
contained 0.23 mg ml"' and none was detected in the fluid collected following 
application of the sample (TBW 5 - IgG).
The thi'ee fractions mentioned above were tested for their ability to react with ovine 
and human B. parapertussis on a western blot but neither TBW 5, TBW 5 -  IgG 
nor purified IgG recognised the human or ovine isolates (results not shown).
3.7. API analysis
The differences between the growth of ovine and human B. parapertussis in TBW 
and NB suggested the possibility of different nutritional requirements. The API 
ZYM kit was used to measure the production of a variety of enzymes by the 
different isolates. The results are presented in Table 3.4.
API ZYM did not detect any significant difference in the production of these 
enzymes by ovine and human B. parapertussis. It is possible that ovine and human 
B. parapertussis do have different nutritional requirements and produce different 
enzymes or different quantities of enzymes that were not assayed for.
Table 3.4. API ZYM results for ovine and human B. parapertussis.
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Concentration of enzymes (nmol) produced by 
isolate:
Enzyme tested for HI K2 B285 NCTC 10520
Alkaline phosphatase 0 0 0 0
Esterase 5 20 20 20
Esterase lipase 5 5 5 5
Lipase 0 0 0 0
Leucine arylamidase >40 >40 >40 >40
Valine aiylamidase 5 5 5 5
Cystine arylamidase 5 5 5 5
Trypsin 0 0 0 0
Chymotrypsin 10 5 5 5
Acid phosphatase 5 5 5 5
N aphtho LAS -B Lpho sphohydrolase 5 5 5 5
a  galactosidase 0 0 0 0
P galactosidase 0 0 0 0
P glucuronidase 0 0 0 0
a  glucosidase 0 0 0 0
P glucosidase 0 0 0 0
N-acetyl-p glucosaminidase 0 0 0 0
a  mannosidase 0 0 0 0
a  fucosidase 0 0 0 0
3.8. Discussion
This study was designed to compare the growth of ovine and human B. 
parapertussis in ovine TBW to detennine if there was any host specificity of these 
isolates. The results indicated that ovine B. parapertussis isolates were capable of 
growth in ovine TBW. As sheep are the natural host of these isolates, their growth 
in these TBW was predictable. However, the rates of growth in the different TBW 
were not consistent. In TBW 1, 2 and 4 there was not a great deal of growth of 
ovine B. parapertussis whereas TBW 3 and 5 showed greater rates of growth.
In comparison, the human isolates either died or stmggled to maintain their 
numbers. This is in contrast to the findings of Porter and Wardlaw (1994) who 
reported that their human strain NCTC 10520 grew in sheep TBW. However,
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NCTC 10520 was one of the human isolates tested in this study. These conflicting 
results and the differences in the growth rates of ovine B. parapertussis in ovine 
TBW suggests that the differences in growth rates were due to the fact that the 
TBW came from different sheep. Therefore, the varying growth rates obseiwed 
may be due to differences in the composition of the TBW.
There were obvious differences between the growth of ovine and human B. 
parapertussis in TBW 3, 4 and 5. This was most noticeable in the death of B285 
in TBW 4 and the death of both human isolates tested, B285 and NCTC 10520, in 
TBW 5. The death of the human isolates in two of the TBW and the fact that the 
difference between growth of the human isolates in all 5 TBW compared to ovine 
isolates is statistically significant suggests some host specificity of the isolates. It 
would have been useful to compare the growth of ovine and human B. 
parapertussis in human TBW to investigate further any possible host specificity 
but these were not available.
Both ovine and human B. parapertussis demonstrated a slow decline in the number 
of viable cells when incubated in PBS over 72 h. This contrasts somewhat with the 
findings of Porter and Wardlaw (1994) who found that their B. parapertussis 
isolate (NCTC 10520) had died in PBS by day 3.
Nutrient broth was used as a positive control as it is known to support the growth 
of B. parapertussis. Observation of the growth of ovine and human B, 
parapertussis revealed that the human isolates grew more slowly than ovine 
isolates in nutrient broth. The difference showed a clear distinction between ovine 
and human B. parapertussis that was statistically significant. While the ovine 
isolates demonstrated a steady initial growth rate over the first 24 h, the human |
isolates went into a lag phase. Following the lag phase, the human isolates grew at
an increased rate. However, the number of viable bacteria did not reach the same |
concentration as the ovine isolates over the duration of the experiments. This
suggests the possibility that human B. parapertussis are more fastidious than ovine
B. parapertussis. It would be interesting to continue this experiment for a longer
period of time to see if the human isolates were capable of reaching the same
concentration of viable cells as the ovine isolates.
The analysis of TBW revealed that all the TBW had similar values for the proteins 
and nutrients tested. The exception was the concentration of potassium in TBW 5, 
which was higher than in the other TBW. The ovine isolates grew in this TBW
j.;-whereas the human isolates died. However, it is unlikely that the higher potassium |
concentration was responsible for the death of the human strains in TBW 5. The
potassium concentration was lowest in TBW 4 yet the human isolate B285 died
and the other TBW contained slightly higher potassium levels but neither of the
human isolates died. It is possible that, because the TBW are washings of the
lungs, some of them may be more dilute than others. However, as mentioned
■Vv
above, all TBW had similar values for the proteins and nutrients tested for. It may #
be that these TBW differed in factors that were not assayed for. It must be noted
that TBW are washings and therefore are dilutions of the fluid normally found in j
lungs. By collecting washings, factors essential for the growth of B. parapertussis
may be diluted to below a critical concentration.
It has been reported that all the bordetellae have an absolute requirement for
nicotinic acid and that amino acids are required as a carbon and nitrogen source. k
The concentration of these nutrients was not assayed for. It is possible that the
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different concentrations of nicotinic acid and amino acids could account for the 
growth differences of B. parapertussis. Although, Porter (1991) reported that the 
number of viable B. parapertussis surviving in a TBW did not vary according to 
the amino acid or nicotinic acid content of the fluid. However, it remains possible 
that different nutritional requirements account for the death of human B. 
parapertussis and survival of ovine B. parapertussis in ovine TBW.
The concentration of IgG purified from TBW 5 was lower than the IgG present in 
whole TBW 5. A possible explanation for this is that the IgG is eluted from the 
column throughout a series of fractions thereby diluting the IgG concentration. f
Although TBW 5 did contain more IgG than the other TBW, Western blots of 
TBW 5 and purified IgG from TBW 5 did not react with any of the B. 
parapertussis tested. It is therefore unlikely that IgG is responsible for the death of 
the two human isolates tested in TBW 5. It is unlikely that IgA caused the death of 
human B. parapertussis in TBW 5 as the main function of secretory IgA (sIgA) in 
the respiratory tract is not as an opsonin but to cross-link target bacteria and trap 
them in the mucus thereby facilitating their clearance by the mucociliary escalator 7
' ::r
(Kraehenbuhl and Neutra, 1992)
The death of human B. parapertussis and survival of ovine B. parapertussis in 
ovine TBW could be due to the production or absence of metabolic enzymes.
However API ZYM, which measures the production of some enzymes, did not 
reveal any difference between the ovine and human isolates. It is possible that 
other differences in enzyme production could be responsible for the death of the 
human isolates and that these enzymes were not tested for using the API ZYM.
Another possiblity, which could account for the growth differences of human and
..tsLK
ovine B. parapertussis in ovine TBW, is that the human and ovine isolates may 
have different susceptibilities to antibacterial factors which may be present in 
TBW. Such factors may include lung surfactant, lysozyme, defensins, fatty acids 
and lactofenin.
In conclusion, the different growth patterns of ovine and human B. parapertussis in 
ovine TBW did suggest some host specificity of the isolates. Moreover, the use of 
TBW from different sheep revealed that the growth rate of B. parapertussis in 
ovine TBW was dependent on the host. The different growth rates of ovine and 
human B. parapertussis in ovine TBW and the slower growth of the human isolates 
in nutrient broth suggest that there are nutritional differences and that the human 
isolates may be more fastidious.
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CHAPTER 4
ADHERENCE OF OVINE AND HUMAN BORDETELLA PARAPERTUSSIS 
TO CELL LINES AND OVINE TRACHEAL ORGAN CULTURES.
4.1. Introduction
In order to establish an infection in the respiratory tract, B. parapertussis has to 
overcome several host defence mechanisms including the mucociliaiy clearance 
mechanism which entraps microorganisms and other foreign particles in the mucus 
layer. The cilia then sweep these trapped particles up from the lower respiratory 
tract and back from the nasal passages where they are either swallowed or expelled 
from the respiratory tract. To avoid clearance, B. parapertussis adheres to the 
ciliated epithelial cells by producing a variety of adhesins, thereby enabling the 
bacteria to colonise the respiratory tract. The ability to adhere to host cells is thus 
an essential step for the establishment of B. parapertussis infection and causation 
of disease.
In this chapter, the aims were to observe the adherence of ovine and human B. 
parapertussis to ovine and human cells including, respiratoiy cell-culture lines and 
ovine tracheal organ culture. The invasion of the cell lines by B. parapertussis was 
also investigated. The assays were designed to detennine any host specificity of 
the ovine and human B. parapertussis isolates tested.
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4.2. Materials and methods
The materials and methods used in this chapter include adherence assays using cell 
lines and ovine tracheal organ culture, which can be found in section 2.3. The 
haemagglutination assay is detailed in section 2.1.2 and the method used for the 
invasion assay is in section 2.4.
4.3. Haemagglutination assay
One of the major adhesins of B. pertussis is filamentous haemagglutinin (FHA) 
(Tuomanen and Weiss, 1985). It is known that B. parapertussis produces a similar 
protein (Locht et a l, 1993) therefore, it is possible that this FHA-like molecule 
also functions as an adhesin.
Serial dilutions of cyclodextrin liquid cultures of ovine and human isolates were 
tested for the production of FHA by comparing their ability to agglutinate sheep 
red blood cells. The results are shown in Table 4.1 where the end point was taken 
as the reciprocal of the highest dilution at which no more agglutination occurred.
Table 4.1. Haemagglutination of sheep red blood cells by ovine and human B, 
parapertussis.
Type Strain End point
Ovine HI 128
IC2 4
Human B285 32
NCTC 10520 32
1 6
4.4. Adherence to ovine and human cell lines
The adherence of ovine and human B. parapertussis to ovine and human non- t
ciliated respiratory epithelial cell lines was observed. The cell lines used were 
foetal lamb turbinate (FLT), foetal lamb lung (FLL) and human foetal lung (MRC-
5). B. parapertussis isolates from cyclodextrin liquid cultures were incubated with 
cells on chamber slides for 60 min at a ratio of approximately 30 bacteria per cell.
The slides were washed then gram-stained and the number of bacteria adhering to 
100 cells were counted.
ï'
Fig. 4.1 displays the adherence of ovine and human B. parapertussis to the cell
lines and shows that the ovine isolate HI was more adherent to these cells than the
other isolates. HI adhered to the ovine cell lines (FLT and FLL) better than ovine i
isolate K2 and both the human isolates. HI also adhered to the human cell line
(MRC-5) better than K2 and the human isolate B285 but slightly less than the other
■
human isolate, NCTC 10520. Although HI adhered to the ovine cell lines more
. ::
than to MRC-5, the difference was not statistically significant (p>0.05, using the 
Mami-Wliitney test) and therefore did not demonstrate any host specificity of this 
isolate.
Ovine B. parapertussis K2 did not adhere to the cells as well as HI and 
demonstrated no preference for ovine cells in comparison with human cells.
Interestingly, the human isolate B285 appeared to adhere better to both the ovine 
cell lines than to MRC-5, whereas, the other human isolate, NCTC 10520, adhered 
better to MRC-5. However, neither of the human isolates specifically
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Fig. 4.1. Percentage adherence of ovine and human B. parapertussis to ovine (FLT 
and FLL) and human (MRC-5) cell lines.
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adhered to one cell type.
4.5. Invasion of cell lines
For this assay, the cell lines used were the same as for the adherence assay (FLT, 
FLL and MRC-5). Bacteria were added to the cells at a concentration of 
approximately 30 per cell and incubated for 5 h, washed, then incubated in 
gentamicin (100 pg mL) for 2 h. The cells were then lysed and plated onto blood 
agar to determine the number of viable intracellular bacteria. To ensure that the 
concentration of gentamicin used killed the bacteria, gentamicin was added to the 
bacterial inoculum for 2 h, in the absence of cells, resulting in a viable count of 
zero. The percentage invasion of the cell lines by ovine and human B. 
parapertussis is shown in Fig. 4.2.
From the results, it is clear that all the isolates tested invaded the human cell line 
(MRC-5) more than the ovine cell lines (FLT and FLL). The invasion of the 
human cell line compared to the ovine cell lines is statistically significant with p = 
0.002 for human isolates and p = 0.0008 for ovine isolates. There was no host 
specificity for the invasion of cell lines and no difference between the invasive 
capacity of ovine and human B. parapertussis for all the cell lines. Overall, the 
invasion of the human cell line by ovine and human isolates was significantly 
greater (p = 0.001) than the invasion of ovine cell lines.
The human cell line (MRC-5) was grown in EMEM whereas the ovine cell lines 
(FLT and FLL) were grown in 199S medium. It is possible that this could cause 
the human cell line to become more susceptible to invasion by B. parapertussis.
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Fig. 4.2. Percentage invasion of ovine (FLL and FLT) and human (MRC-5) cell 
lines by ovine and human B. parapertussis.
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FLT were grown in EMEM and the invasion by ovine and human B, parapertussis 
was again deteraiined.
Table 4.2. B. parapertussis invasion of FLT cells grown in different media.
Isolate 199S EMEM
HI 0.13 % 0.20%
K2 0.01 % 0.02%
B285 0.05 % 0.04 %
NCTC 10520 0.05 % 0.09%
The results showed that the change of growth media only marginally increased the 
invasion of thr ee of the isolates. It is therefore unlikely that the growth medium 
affects the invasion of the cell lines. A comparison of the ovine and human cell 
lines grown in 199S was not possible because the MRC-5 could not grow in this 
medium.
4.6. Adherence to ovine tracheal organ culture
The adherence of ovine and human B. parapertussis to ovine tracheal rings was 
compared. Pasteurella haemolytica A2, an ovine respiratory pathogen, was 
included to determine if this bacterium could adhere to ovine trachea as efficiently 
as B. parapertussis and also to investigate a possible interaction between these two 
species in the ovine respiratory tract.
Tracheal rings were infected with approximately 3 x 10^  cfu m f‘ of bacterial 
suspension and incubated for 1 h. The inside of the rings were then washed and 
scraped to remove adherent bacteria. The number of viable adherent bacteria was 
determined by viable counts. Fig. 4.3. is a photograph of ovine B. parapertussis
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?Fig. 4.3. Scanning electron micrograph of ovine B. parapertussis isolate C 
adhering to the cilia of ovine tracheal organ culture (experiment carried out by 
J.F.Porter).
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isolate C adhering to the tip of the cilia of an ovine tracheal organ culture. A 
comparison of the adherence of ovine and human B. parapertussis and P. 
haemolytica A2 is shown in Fig. 4.4.
The ovine strains adhered to ovine tracheal rings at a rate that was significantly 
different from the human strains (p <0.03), suggesting that ovine B. parapertussis 
adhere better than human B. parapertussis to ovine tracheal rings. P. haemolytica 
A2 also adhered better than the human B. parapertussis isolates to ovine tracheal 
rings. There was no significant difference between the adherence of the ovine 
isolates HI and K2 which suggests little variation within the ovine B. parapertussis 
in ability to adhere to ovine tracheal organ. This was also the case for the human 
isolates.
4.6.1. Interaction of HI siipernate and P. haemolytica A2
B. pertussis culture supemate, which contains the adhesins FT and FHA, has been 
reported to enliance the adherence of other respiratory pathogens (Tuomanen, 
1986). The supemate of a 72 h shaking culture of B. parapertussis HI in 
cyclodextrin liquid was used to try to enliance the adherence of P. haemolytica A2 
to ovine tracheal rings. This supemate was assayed for the presence of FHA using 
the haemagglutination assay detailed in section 2.1.2. The assay showed that FHA 
was present in the supemate (titre = 4). The results of adherence of P. haemolytica 
A2 with B. parapertussis HI culture supemate to ovine tracheal rings are shown in 
Fig. 4.5. A control experiment replacing the HI supemate fluid with cyclodextrin 
liquid (the media used for the growth of B. parapertussis HI) was also earned out
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Fig. 4.4. Percentage adherence of ovine and human B. parapertussis and P. 
haemolytica A2 to ovine tracheal ring organ culture.
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Fig. 4.5. Percentage adherence of P. haemolytica A2 to ovine tracheal ring organ 
culture following incubation with B. parapertussis HI culture supernatant.
Methods used to alter the adherence of P. haemolytica A2 to ovine tracheal rings:
H + A/1 - HI supemate added to rings for 1 h then removed and A2 added to rings. 
H + A/2 - HI supemate added to rings for 3 h then removed and A2 added to rings. 
H + A/3 - A2 incubated in HI supemate for 1 h at 37°C then washed and added to 
rings.
H + A/4 - A2 suspension prepared in HI supemate.
Fig. 4.6. Control experiment - percentage adherence of P. haemolytica A2 to ovine 
tracheal ring organ culture following incubation with cyclodextrin liquid medium. 
See legend for Fig. 4.5 for an explanation of the abbreviations used.
85
0üc
0
0.C
■ D<
H + A/1 H + A/2
Strains
H + A/3 H + A/4
Strains
and these results are displayed in Fig. 4.6.
Fig. 4.5. clearly shows that HI culture supernatant decreased the adherence of P. 
haemolytica A2 to tracheal organ culture with the exception of H + A/1 where the 
adherence of A2 was marginally, but not significantly, increased. However, the 
graph of the controls (Fig. 4.6.) shows the same pattern for the adherence of A2 
when HI culture supernatant is replaced with cyclodextrin liquid, except for A/2 
where the adherence of P. haemolytica A2 increased. A comparison of A2 versus 
A/2 and H+A/2 versus A/2 revealed that neither were statistically significant.
4.7. Discussion
The adherence of P. parapertussis to cell lines revealed that the isolates tested 
were capable of adhering to cell lines within an hour of incubation and that an 
inoculum of approximately 30 bacteria per cell was sufficient for obseiwing the 
bacterial adherence. This contrasts with previous studies of Bordetella pertussis 
where an inoculum of approximately 1000-10000 bacteria per cell and an 
incubation time of up to 5 h were required (Funnell and Robinson, 1993; Redhead, 
1985). These assays resulted in percentage adherence of up to 11% (Redhead, 
1985). In comparison, the adherence assays presented here resulted in adherence 
of up to 40%. However, the difference in percentage adherence may be because a 
higher inoculum was used by Redhead (1985) and although 11% adherence 
appears low, it represents a much higher number of bacteria per cell than the assays 
presented in this chapter.
The adherence assay using continuous cell lines did not show any host specificity
86
ï*of the ovine and human isolates. Although the ovine isolate HI appeared to adhere 
to the ovine cell lines better than to the human cell line, this difference was not 
statistically significant. This was also the case for the human isolate NCTC 10520 
which adhered better to the human cell line than to the ovine cell lines. The lack of 
host specificity of the isolates suggests the possibility of a potential transfer of B. 
parapertussis infection between humans and sheep.
The invasion assay used in this chapter was based on that of Ewanowich et al. 
(1989) who studied the invasion of HeLa cells by human B. parapertussis. Their 
findings suggested that B. parapertussis was as invasive as Salmonella and 
Shigella which are able to invade host epithelial cells as part of their disease cycle. 
The results presented here show that both the ovine and human B. parapertussis 
isolates did not invade the ovine cell lines particularly well (Fig. 4.2). However, 
both the ovine and human isolates invaded the human cell line. The invasion of 
cell lines was not host specific, in that the human isolates did not invade the human 
cell line better than the ovine isolates.
It is interesting that both ovine and human B. parapertussis could invade the 
human cell line (MRC-5) much more than the ovine cell lines. However, the ovine 
and human cell lines were grown in different media but when the ovine cell lines 
were grown in the same medium as MRC-5 there was little change in the invasion 
of these cells by B. parapertussis. MRC-5 were not able to grow in 199S which 
suggests that these cells require a more specialised medium than ovine cells. It is 
possible that because the human cell line is more difficult to grow in tissue culture 
it is weaker than the ovine cells and therefore more susceptible to invasion by B. 
parapertussis. Alternatively, both ovine and human B. parapertussis may
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recognise specific receptors on the human cells which enable the invasion of these
cells but the same receptors may not be present on the ovine cells.
It was expected that as adherence is considered necessaiy for invasion, the ovine 
isolates would invade the ovine cell lines at a higher rate than the human cell line 
since they adhered preferentially to ovine cells. Yet, none of the isolates invaded
•fthe ovine cell line particularly well despite adhering to these cells. This is notable A-
in the case of HI which demonstrated good adherence to the ovine cell lines but •:
1
very little invasion of these cells. However, the ovine isolate HI and the human
!
isolate NCTC 10520 adhered to and invaded the human cell line better than the
other isolates. This does suggest that binding of the bacteria to cells may enhance <i-:
any subsequent invasion of cells by both ovine and human B. parapertussis.
The ovine isolate HI was overall more adherent and invasive than any of the other 
isolates tested (Fig. 4.1 and Fig. 4.2). This is possibly due to the higher production 
of the adhesin FHA by HI compared with the amount produced by the other 
isolates. NCTC 10520 and B285 produced equal amounts of FHA (Section 4.3).
However, NCTC 10520 adhered to and invaded the human cell line (MRC-5) 
better than B285. This suggests a possible role for another adhesin, possibly 
pertactin (PRN), in the adherence to and invasion of cell lines by B. parapertussis.
It may be that PRN plays a role in the ability of NCTC 10520 to invade the human 
cell line by enhancing the adherence of this isolate to the cell and thus increasing 
the chance of uptake into the cell. It would have been interesting to compare the 
amount of PRN produced by B285 and NCTC 10520 to see if different 
concentrations of this protein were produced and if it affected the ability of these 
bacteria to adhere to and invade cells.
  '  ^ ' " S
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Previous studies have shown that PRN plays an important role in the adherence of 
B. pertussis to various cell lines e.g. Chinese hamster ovary cells and HeLa cells 
(Leininger et al., 1991; Arico et al., 1993). Leininger et al. (1991) found that the >
absence of PRN resulted in 30-40% less adherence of these bacteria to cells. The I
role of PRN in the invasion of cell lines by B. pertussis has already been suggested 
by Lee et al. (1990) and Everest et al. (1996). B. pertussis and B. parapertussis fi
Iproduce pertactins which are not identical but are very similar (Li et al., 1991).
Therefore, it is possible that the PRN of B. parapertussis may also play a role in 
adherence and invasion.
B. parapertussis also possess agglutinogens (Eldering et al., 1957) and some of 
them may be located on fimbriae. The precise role of B. parapertussis fimbriae 
has not been defined. It may be that they are also involved in the adherence of B. 
parapertussis to target cells. However, the fimbriae of B. pertussis do not appear 
to play a role in attachment to the cilia or respiratoiy epithelial cells which are the 
natural location of this species (Tuomanen, 1988). Yet, they do enable the 
organism to bind to other mammalian cells including Vero cells (Gomnge et al.,
1985) and HeLa cells (Sato et al, 1981). It is possible that the fimbriae of B. 
parapertussis also play a role in adherence to continuous cell culture lines, such as 
those used in this chapter. Any adherence caused by fimbriae could be detected by 
examining the interaction of the bacteria and cells using electron microscopy or by 
the use of monoclonal antibodies to specific fimbriae which may block the 
adherence of B. parapertussis to the cells.
Cell lines are convenient in vitro systems that can be used to investigate the 
adherence of bacteria. However, these cells cannot accurately reflect an in vivo A
;f:,
. I
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situation because the cells will have adapted to a different environment and cellular 
structures such as cilia are missing, B. pertussis has been shown to attach 
primarily to the cilia of human respiratory epithelial cells (Tuomanen and Hendley, 
1983) and it is logical to assume that B. parapertussis also adheres preferentially to 
cilia.
Tracheal organ culture allows study of the adherence of Bordetella species to 
ciliated host epithelial cells and the use of ovine tracheal organ culture revealed 
possible host specificity of B, parapertussis. The adherence of ovine isolates to 
ovine tracheal rings was significantly different to the adherence of human isolates 
to these rings (p < 0.03). An interesting comparison would be to measure the 
adherence of ovine and human B. parapertussis to human or primate tracheal rings 
to see if there is indeed some host specificity of the interaction between these 
different isolates with tracheal organ cultures. The possibility of host specific 
adherence of Bordetella species has already been investigated. Using human and 
animal ciliated cells, Tuomanen et al. (1983) demonstrated that the human B. 
parapertussis isolate tested adhered better to human ciliated cells than to those 
from rabbits, mice or hamsters. There was no significant difference between the 
adherence of the ovine isolates HI and K2 to tracheal rings which suggests little 
variation within ovine B. parapertussis in the ability to adhere to ovine tracheal 
organ culture. Similarly, there was little difference in adherence between the two 
human isolates to the ovine tracheal rings.
P. haemolytica is a respiratory tract pathogen of sheep and a major cause of ovine 
pneumonia. This species is usually found in the upper respiratory tract of clinically 
healthy sheep and causes disease when the host is predisposed. It has been
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suggested that B. parapertussis colonises the respiratory tract of sheep and this 
predisposes the host to a secondary infection caused by P. haemolytica (Jian et a l,
1991; Porter e/a/., 1995a).
The adherence of P. haemolytica A2 to ovine tracheal organ culture was also f
demonstrated. Using this assay, P. haemolytica was more adherent to tracheal .f
rings than one of the ovine and both of the human isolates of P. parapertussis (Fig. j
4.4). In fact, P. haemolytica adhered to the tracheal rings almost as well as the 
ovine B. parapertussis HI. It has been reported that P. haemolytica have fimbriae 
(Morck et al, 1987; Morck et al., 1988) but the adherence mechanisms of P. 
haemolytica are unknown.
Tuomanen (1986) reported that adhesins secreted by B. pertussis (FHA and FT) 
could be used by other pathogenic bacteria, such as Streptococcus pneumoniae,
Haemophilus influenzae and Staphylococcus aureus, to enhance their adherence to 
ciliated cells. It was suggested that such piracy of adhesins may contribute to 
secondary infections during whooping cough. It is possible that piracy of B. 
parapertussis adhesins aids the establislunent of P. haemolytica infection in sheep. 
However, the supemate of ovine B. parapertussis HI increased or decreased the 
adherence of P. haemolytica A2 depending on the method used (Fig. 4.6.). 
Moreover, a control experiment using uninfected growth medium instead of culture 
supernatant resulted in the same findings (Fig. 4.7.), with one exception. When the 
HI supernatant was incubated with tracheal rings for 3 h prior to infection with P. 
haemolytica A2, the adherence of P. haemolytica A2 to the rings decreased. The 
control experiment showed the uninfected growth medium to increase the 
adherence of P. haemolytica A2. All the other methods in this experiment
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involved an incubation of P. haemolytica A2 and HI supernatant of 1 h. It may be 
that a longer incubation time of 3 h resulted in B. parapertussis adhesins binding to 
the cells thereby preventing the binding of P. haemolytica. This suggests that the 
two microorganisms are competing for the same receptors.
B, parapertussis may allow the establislrment of P. haemolytica infection of the 
respiratory tract by the production of B. parapertussis toxins which damage host 
cells thereby enabling P. haemolytica to cause disease. It is likely that ovine B. 
parapertussis produce tracheal cytotoxin (TCT) and the heat-labile toxin (HLT). 
TCT is produced by human B. parapertussis and causes damage to the ciliated 
epithelium of the trachea leading to sloughing of the cilia (Goldman, 1988). It has 
already been suggested that TCT is responsible for the damage of ciliated epithelial 
cells observed in lambs and mice infected with ovine B. parapertussis (Chen et a l, 
1990). This would prevent efficient clearance of an infectious agent such as P. 
haemolytica which could then establish an infection. A similar interaction has 
been suggested in swine atrophic rhinitis. Chanter et al. (1989) proposed that the 
TCT of B. bronchiseptica caused ciliostasis and this allowed colonisation of the 
nasal passages by Pasteurella multocida. Ovine B. parapertussis may also 
produce HLT, a toxin which is known to be produced by human B. parapertussis 
(Walker and Weiss, 1994). The HLT of B. bronchiseptica may have a role in 
producing the turbinate atrophy associated with swine atrophic rhinitis (Rutter and 
Mackenzie, 1984). These actions of HLT could result in a secondary infection of 
the host respiratoiy tract.
The adherence assays presented here have suggested some host specificity in the 
adherence of ovine and human B. parapertussis to ovine tracheal organ culture. It
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would have been useful to compare the adherence of the different isolates to human 
tracheal organ culture to clarify this point. Also, the invasion of the human cell 
line by P. parapertussis indicated the importance of adherence as a prerequisite for 
invasion. It would be interesting to look further into the role of FHA and PRN in 
the adherence of both the ovine and human isolates to tracheal rings and to 
detemiine if the differences in the adherence and invasion of the two human strains 
were caused by the production of PRN. This could be accomplished by the use of 
monoclonal antibodies to FHA or PRN or by the addition of FHA or PRN to 
organisms deficient in the production of these proteins. The adherence of P. 
haemolytica A2 to tracheal rings and a possible inhibition of adherence by the 
actions P. parapertussis vimlence factors waiTants further investigation.
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CHAPTER 5
INTERACTION OF OVINE AND HUMAN BORDETELLA 
PARAPERTUSSIS WITH ALVEOLAR MACROPHAGES 
5.1. Introduction
Alveolar macrophages are the first line of host defence against bacterial invasion of 
the lower respiratory tract. Studies have shown that P. pertussis can adhere to 
pulmonary macrophages and also invade and survive intracellulaidy (Saulckonen et 
al, 1991; Friedman et a l, 1992), P. pertussis is also capable of multiplying within p
macrophages thereby providing a possible reseiwoir of viable bacteria capable of 
causing further infection (Guierard et al, 1998). There are no reports of the 
interaction of P. parapertussis with macrophages and whether these bacteria can 
survive phagocytosis although their ability to invade and survive within other cell s
■f
types, such as HeLa cells has been shown (Ewanowich et a l, 1989). This study 
compared the interaction of ovine and human P. parapertussis with ovine alveolar 
macrophages and the survival of these bacteria once internalised within the cells.
5.2. Materials and methods
The interaction of ovine P. parapertussis HI and K2 and human P. parapertussis 
B285 and NCTC 10520, Pasteurella haemolytica A2 and Corynebacterium bovis 
with alveolar macrophages was studied in this chapter. Bacterial adherence,
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intracellular uptake and survival within macrophages was studied using the assays 
detailed in section 2.5.
5.3. Adherence of P. parapertussis to ovine alveolar macrophages
B. parapertussis isolates were incubated for 90 min with freshly prepared ovine 
alveolar macrophages at a ratio of approximately 30 bacteria per cell. The slides 
were then washed, fixed with fonnol saline and the number of bacteria adhering to 
100 macrophages was counted. The percentage adherence to ovine alveolar 
macrophages is shown in Fig. 5.1.
As with the adherence to cell lines and tracheal organ culture (chapter 4), the ovine 
isolate HI adhered to the macrophages better than the other isolates tested. K2, an 
ovine isolate, adhered to the ovine alveolar macrophages better than both the 
human isolates and B285 adhered to the macrophages more than NCTC 10520. 
Both P. haemolytica A2 and C. bovis adhered to the ovine alveolar macrophages.
5.4. Macrophage uptake of B, parapertussis
The use of a differential fixation technique allowed calculation of the macrophage 
uptake of ovine and human B. parapertussis. Fixing the cells with methanol 
penneabilises the macrophage cell membrane and allows the visualisation of both 
intracellular and extracellular bacteria. In comparison, fixation with formol saline 
allows only extracellular bacteria to be observed. Therefore, the difference
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Fig. 5.1. Adherence of ovine (HI and K2) and human (B 285 and NCTC 10520)
B. parapertussis to ovine alveolar macrophages following 90 min incubation.
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%Table 5.1. Comparison of ovine macrophage uptake of ovine and human B. 
parapertussis after incubation for 90 min.
Isolate % Intracellular
_  ^
IC2 0.63 ± 0.63
B 285 0.13 + 0.13
NCTC 10520 0.12 + 0.09
P. haemolytica A2 0.00 ± 0.00
C. bovis 0.31 + 0.31
Table 5.1. shows that the uptake of ovine isolate HI into ovine alveolar 
macrophages is higher than the uptake of the other isolates. This correlates with 
the comparison of adherence of the ovine and human isolates where HI adhered to 
the macrophages greater than the other isolates. P. haemolytica A2 was used as a 
positive control because it acts quickly on the macrophage, possibly through the 
action of its leukotoxin, and at 90 min,
between these two methods enables the calculation of the number of intracelluar 
bacteria. Pasteurella haemolytica A2 was used as a positive control as it has been 
shown to destroy macrophages with 90 min of incubation (Rowe, 1997) and 
Corymebacterium bovis was used as a negative control.
Fig 5.2 A shows the interaction of ovine P. parapertussis HI with the macrophages 
as visualised using foimol saline as a fixative. Here, the bacteria can be seen 
adhering to the cell. Methanol fixation was used in Fig. 5.2. B and this shows both 
extracellular and intracellular bacteria associated with ovine alveolar macrophages.
f:'
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Fig. 5.2A. Photographic representation of B. parapertussis Fil interaction with an 
ovine alveolar macrophage using methanol fixation where both intracellular and 
extracellular bacteria can be visualised, x 1000 magnification.
Fig. 5.2B. Photographic representation of B. parapertussis HI adhering to an 
ovine alveolar macrophages using formol saline fixation, x 1000 magnification.
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as expected, some of the macrophages were destroyed and no bacteria were 
intracellular. In comparison, internalisation of C bovis appears to take longer.
5.5. Survival of B. parapertussis within ovine alveolar macrophages
To detennine the number of viable intracellular bacteria, a phagocytosis assay was 
performed as above except, following the 90 min incubation, the cells were 
incubated in gentamicin for 60 min to kill any extracellular bacteria. The 
macrophages were then washed, lysed and dilutions of the resulting suspension 
were plated onto blood agai- to determine the number of viable intracellular 
bacteria. The resulting number of viable bacteria were expressed as a percentage 
of the intracellular bacteria calculated in the preceding section. The results are 
shown in Table 5.2.
Table 5.2. Survival of phagocytosed B. parapertussis, expressed as % of 
intracellular bacteria.
Isolate % Suiwival of intracellular bacteria
___ 10.70 + 7.61
K2 0.298 ± 0.298
B285 1.44+ 1.44
NCTC 10520 8.85 + 6.43
P. haemolytica A2 0 + 0
C. bovis 0 + 0
A proportion of all the B. parapertussis isolates survived phagocytosis however, it 
is clear that the ovine isolate HI survived phagocytosis better than the other 
isolates, although this was not significant. The survival of ovine isolate K2 was 
lower than that of HI and both of the human isolates.
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Fig. 5.3. Phagocytic survival of B. parapertussis after 90 min incubation compared 
with the inoculum used.
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Fig. 5.3 shows the phagocytic survival of B. parapertussis compared to the 
inoculum. Here, a higher proportion of HI suiwived phagocytosis compared to the 
other isolates tested. This also reinforces the findings above which stated that 
compared with the other B. parapertussis, K2 did not suiwive phagocytosis as well 
as the others.
5.6. Effect of opsonisation on phagocytosis
Bacteria were pre-treated with sera and TBWs to detennine if opsonisation by any 
of these fluids affected bacterial survival following phagocytosis.
5.6.1. Bacterial adherence following opsonisation
Bacteria were opsonised by incubation with antisera or TBW for 15 min at room 
temperature. Following opsonisation, the bacteria were washed and added to the 
macrophages. The assay was then carried out as for section 5.3. Lamb antisera 
against ovine B. parapertussis HI and human B. parapertussis NCTC 10520, 
TBW 5 and TBW 5 - IgG were used as opsonins.
The adherence of ovine and human B. parapertussis to ovine alveolar macrophages 
following opsonisation is shown in Fig. 5.4-5.7. Opsonsisation with lamb sera 
raised against HI and NCTC 10520 increased the adherence of ovine isolate HI 
and both of the human isolates. However, this resulted in little difference to the 
adherence of IC2 to the macrophages. In all cases, opsonisation with TBW 5 - IgG
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Fig. 5.4. Percentage adherence of ovine B. parapertussis HI to macrophages 
following opsonisation with LS HI (lamb serum raised against HI), LS NCTC 
(lamb serum raised against NCTC 10520), TBW 5 and TBW 5 - IgG.
Fig. 5.5. Percentage adherence of ovine B. parapertussis K2 to macrophages 
following opsonisation with LS HI (lamb serum raised against HI), LS NCTC 
(lamb serum raised against NCTC 10520), TBW 5 and TBW 5 - IgG.
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Fig. 5.6. Percentage adherence of human B, parapertussis B285 to macrophages 
following opsonisation with LS HI (lamb serum raised against HI), LS NCTC 
(lamb serum raised against NCTC 10520), TBW 5 and TBW 5 - IgG.
Fig. 5.7. Percentage adherence of human B. parapertussis NCTC 10520 to 
macrophages following opsonisation with LS HI (lamb semm raised against HI), 
LS NCTC (lamb semm raised against NCTC 10520), TBW 5 and TBW 5 - IgG.
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did not significantly affect the adherence of ovine and human B, parapertussis to 
macrophages. Opsonisation with TBW 5 had little effect on the adherence of HI, 
B285 and NCTC 10520 to ovine alveolar macrophages but, this fluid did decrease 
the adherence of K2, although not significantly.
5.6.2. Bacterial uptake following opsonisation
Table 5.3. % Intracellular bacteria within ovine macrophages following
opsonisation with the following sera and TBWs.
% Intracellular
Isolate Control Lamb serum 
a-H l
Lamb serum
a-NCTC
10520
TBW 5 TBW 5 - IgG
HI
K2
B285
NCTC 10520
0.64 + 0.39 
0.00 ± 0.00 
0.10 + 0.10 
0.26 ± 0.26
1.88 ± 1.88 
2.41 ±2.41 
0.80 + 0.68 
0.03 ± 0.03
2.30+1.70 
3.75 ±3.43 
2.83 ±2.66 
3.71 ± 1.88
0.16 + 0.15 
0.00 + 0.00 
0.13 + 0.11 
0.07 + 0.01
0.34 + 0.34 
0.52 + 0.40 
1.85 + 1.03 
0.64 + 0.62
As shown above, opsonisation of all the isolates with lamb serum raised against 
NCTC 10520 increased the macrophage uptake of the bacteria. However, when the 
bacteria were pre-incubated with lamb serum raised against HI the intracellular 
count of all the isolates except NCTC 10520 was increased. Opsonisation with 
TBW 5 only increased the uptake of B285 whereas opsonisation with TBW 5 - IgG 
increased the uptake of all the isolates except HI.
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5.6.3. Survival within macrophages following opsonisation
Table 5.4. % Survival of phagocytosed B. parapertussis following opsonisation 
with the following fluids and sera. The suivival is expressed as % of intracellular 
bacteria.
% Survival
Isolate Control Lamb semm 
a~Hl
Lamb semm
a-NCTC
10520
TBW 5 TBW 5 - IgG
HI
K2
B285
NCTC 10520
2.7+1.54 
0 + 0
7.78 + 7.78 
6.41+6.41
0.48 + 0.48
0.317±
0.317
35.3 ±32.4
33.3 ±33.3
3.12 + 2.07 
2.64 ± 2.32
11.4+ 10.7 
0.547 ± 0.289
33.8 + 26 
0 + 0
37.9 + 31.3 
58.3 + 21.1
3.93 + 3.93 
16.35 + 8.53
3.16+1.80 
2.59 + 2.59
From the data above opsonisation with anti-Hl lamb serum increased the 
intracellular survival of B285, NCTC 10520 and K2 but decreased the suivival of 
HI. However, opsonisation with anti-NCTC 10520 lamb serum increased the 
survival of intracellular HI, K2 and B285 but decreased the survival of NCTC 
10520. The use of TBW 5 as an opsonin either increased or had no effect on the 
suivival of intracellular B. parapertussis. In comparison, opsonisation with TBW 
5 - IgG resulted in the increased survival of ovine B. parapertussis but the survival 
of human B. parapertussis decreased.
The survival of opsonised B. parapertussis within ovine alveolar macrophages was 
monitored as in section 5.5. The number of viable bacteria recovered upon lysis of 
the macrophages are shown in Fig. 5.8 - 5.11. These graphs show that the number 
of viable bacteria recovered from the macrophages was not affected by 
opsonisation. This contrasts with the data in Table 5.4. which showed that the 
suivival of B. parapertussis, when expressed as a % of intracellular bacteria, varied 
when the bacteria were opsonised.
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Fig. 5.8. Suivival of ovine B. parapertussis HI within ovine alveolar macrophages 
following opsonisation. Opsonins used were LS HI (lamb serum raised against 
HI), LS NCTC (lamb semm raised against NCTC 10520), TBW 5 and TBW 5 - 
IgG.
Fig. 5.9. Suivival of ovine B. parapertussis K2 within ovine alveolar macrophages 
following opsonisation. Opsonins used were LS HI (lamb semm raised against 
HI), LS NCTC (lamb semm raised against NCTC 10520), TBW 5 and TBW 5 - 
IgG.
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Fig. 5.10. Suivival of human B. parapertussis B 285 within ovine alveolar 
macrophages following opsonisation. Opsonins used were LS HI (lamb serum 
raised against HI), LS NCTC (lamb serum raised against NCTC 10520), TBW 5 
and TBW 5 - IgG.
Fig 5.11. Survival of human B. parapertussis NCTC 10520 within ovine alveolar 
macrophages following opsonisation. Opsonins used were LS HI (lamb serum 
raised against HI), LS NCTC (lamb semm raised against NCTC 10520), TBW 5 
and TBW 5 - IgG.
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Opsonisation of ovine and human B. parapertussis did not appear to significantly 
affect the survival of these isolates within alveolar macrophages when compared to 
the survival of unopsonised bacteria. The use of opsonins resulted in little 
difference between the suivival of ovine and human isolates.
5.7. Effect of prolonged incnbation on intracellnlar snrvival
Ovine and human B. parapertussis survival within ovine and porcine alveolar 
macrophages was monitored over 48 h. Briefly, the survival was earned out as 
before except that following the addition of gentamicin, the cells were washed then 
10 pg m f' polymyxin was added to kill any bacteria which may leave the 
macrophages during the 24 h or 48 h incubation. Following incubation, the cells 
were washed then lysed and dilutions plated onto blood agar to determine the 
number of viable intracellular bacteria. To ensure that the concentration of 
polymyxin used would kill any bacteria present, each B. parapertussis isolate was 
incubated for 24 h and 48 h in 10 pg ml"' polymyxin in the absence of 
macrophages.
The survival rates represented in Fig. 5.12 show that by 24 h, both the ovine isolate 
K2 and human isolate NCTC 10520 had increased in numbers while both Ell and 
B285 had decreased. Flowever, after incubation for 48 h the survival of the human 
isolates had decreased whereas the survival of the ovine isolates had increased.
Fig. 5.13 represents the survival of B. parapertussis within porcine alveolar 
macrophages over 48 h and shows that the number of viable intracellular bacteria
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Fig. 5.12. Suivival of ovine (HI and K2) and human (B 285 and NCTC 10520) B. 
parapertussis within ovine alveolar macrophages over 48 h.
Fig. 5.13. Survival of ovine (HI and K2) and human (B 285 and NCTC 10520) B. 
parapertussis within porcine alveolar macrophages over 48 h.
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for both ovine and human isolates decreased over the first 24 h. However, after 48 
h, the decline in survival of ovine isolates continued whereas the numbers of 
human isolates had begun to recover.
5.8. Discussion
Until recently the bordetellae were thought to be obligate extracellular pathogens 
with no known environmental reservoirs of infection. However, research into the 
intracellular capabilities of both B. pertussis and B. bronchiseptica has revealed 
these species can invade, and sui*vive within, epithelial cells (Lee et al., 1990; 
Schipper et a i, 1994), polymoiphonuclear leucocytes (Steed et al., 1992; Register 
et al., 1994) and macrophages (Saukkonen et al., 1991; Friedman et al., 1992; 
Forde et al., 1998).
The interaction of B. parapertussis with macrophages has been little studied which 
is perhaps surprising considering that its two closest relatives in the Bordetella 
genus, B. pertussis and B. bronchiseptica, have been shown to use different 
mechanisms for the entry into and survival within these cells. B. pertussis uses 
Z)vg -^activated factors such as FHA, PT and ACT for phagocytosis and sui-vival 
within macrophages (Friedman et al., 1992), whereas, the expression of bvg- 
activated factors is not necessary for the uptake and intracellular survival of B. 
bronchiseptica (Banemann and Gross, 1997).
The adherence of B. pertussis to macrophages is dependent upon the production of 
PT which interacts with carbohydrate receptors on the cell surface, and on FHA 
which interacts with both caihohydrate receptors and the macrophage integrin CR3
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(Reiman et al., 1990; Saulckonen et al., 1991). Both these factors can 
independently mediate the adherence o f B. pertussis to macrophages (Reiman et 
al, 1990) yet the presence of PT entrances the binding of FHA to CR3 (vanT Wont 
et a l, 1992). The mechanism of B. parapertussis adherence to macrophages has 
not been deteimined. However, this species does not produce PT therefore it is 
likely that FHA is the major adhesin. The results presented in this study (Fig 5.1) 
show that ovine isolate HI was more adherent to ovine alveolar macrophages than 
the other isolates tested. This isolate produced more FHA than the other isolates 
(Chapter 4) and suggests that FHA plays an important role in the adherence of B. 
parapertussis to macrophages. The ovine isolate K2 was found to produce less 
FHA than B285 and NCTC 10520 yet this isolate adhered better than the human 
isolates which suggests either that there is some host specificity of the isolates or 
that K2 produces more of another adhesin, such as PRN. Friedman et al. (1992) 
suggested a role for PRN in the attachment of B. pertussis to macrophages and this 
may also be the case for B. parapertussis.
Investigation into intracellular entry of B. parapertussis into ovine alveolar 
macrophages (Table 5.1) showed that ovine isolate HI had a greater level of uptake 
compared with ovine isolate K2 and the human isolates. Friedman et al. (1992) 
showed that FHA is important for the internalisation of B. pertussis into 
macrophages following interaction of the RGD sequence on FHA with the 
macrophage integrin CR3 (Reiman et a l, 1990; Sauklconen et a l, 1991). HI 
produced more FHA than the other B. parapertussis therefore it is possible that the 
higher macrophage uptake of this isolate is due to the presence of FHA. This 
suggests a possible uptake mechanism of B. parapertussis similar to that of B.
I l l
:pertussis. B285 and NCTC 10520 were found to produce similar concentrations of 
FHA yet a higher concentration of NCTC 10520 was internalised. PRN also 
contains an RGD sequence which may interact with CR3 thereby enabling =l
macrophage uptake of the bacteria. The PRN of B. pertussis plays a role in the 
invasion of Hep-2 (Roberts et al., 1991) and HeLa (Leininger et al., 1992) cells 
and a possible role for PRN in macrophage uptake of B. pertussis has been 
suggested by Friedman et al. (1992).
Intracellular uptake is dependent upon the initial adherence of bacteria to cells.
Since the ovine isolates adhered to ovine alveolar macrophages better than the 
human isolates, ovine B. parapertussis, as expected, invaded the macrophages 
better than human B. parapertussis. It would be interesting to screen more strains 
of ovine and human B. parapertussis to deteimine if the interaction between B. 
parapertussis and macrophages is host specific.
The uptake of ovine and human B. parapertussis in this study was approximately 
0.1-14.5%. Such large variation of uptake is possibly due to the production of 
different concentrations of the necessary virulence factors by the four isolates 7
tested and may also be due to some host-specificity of the isolates. This value is 
similar to those from studies of B. pertussis and B. bronchiseptica in which the 
bacterial uptake was 1-12.4% (Friedman et al., 1992; Banemann and Gross, 1997;
Forde et al., 1998).
The adherence of all the isolates except K2 increased following opsonisation with 
lamb serum. The use of TBW 5 as an opsonin either decreased or had no effect on 
the adherence of the isolates whereas, TBW 5 - IgG had little effect on the 
adherence of both ovine and human B. parapertussis. However, this did not
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completely correlate with the number of intracellular bacteria. Opsonisation with 
lamb serum increased both the adherence and intracellular count of HI and B285 
but using lamb semm raised against HI increased the adherence of NCTC 10520 
but decreased the number of intracellular bacteria. Also, opsonisation with lamb 
serum reduced the adherence of K2 but increased the intracellular uptake of this 
isolate. Opsonisation with TBW 5 decreased the adherence and the number of 
intracellular bacteria for all the isolates. Whereas, opsonisation with TBW 5 - IgG 
had little effect on the adherence of ovine and human isolates but this increased the 
intracellular count of all isolates except HI.
Opsonisation with lamb semm raised against the human isolate NCTC 10520 
increased the intracellular uptake of all the isolates. Yet, opsonisation with lamb 
semm raised against ovine isolate HI decreased the uptake of NCTC 10520 and the 
uptake of B285 was not as high as with the other serum. It is possible that the 
lamb serum raised against HI did not interact with the human isolates as 
effectively as the other semm and this resulted in a reduced uptake when compared 
with opsonisation using lamb semm raised against NCTC 10520. It may be that 
the two sera react to different antigens present on the bacterial cell surface and that 
on the surface of human B. parapertussis these antigens may be masked, resulting 
in less interaction with the bacteria and ultimately, less macrophage uptake.
Human bronchoalveolar lavage fluid has been shown to stimulate phagocytosis due 
to the presence of natural opsonins such as surfactant protein A, which can act as a 
stimulator of phagocytosis (Tino and Wright, 1996). In this study, TBW 5 only 
slightly increased the intracellular count of one of the isolates, B285. In the 
absence of IgG this TBW increased the macrophage uptake of ovine isolate K2 and
113
both the human isolates. This suggests that the IgG in TBW 5 may somehow 
prevent the uptake of bacteria when they are pre-incub ated in this fluid. However, 
in chapter 3, neither TBW 5 nor any purified IgG from this fluid reacted with ovine 
and human B. parapertussis. It is possible that the purification procedure also 
removed some other antimicrobial component(s) of the fluid. The low bacterial 
uptake following incubation with TBW 5 may be due to antimicrobial factors 
present in TBW such as peptides, free fatty acids and lysozymes, which have been 
found to be bactericidal (Coonrod, 1986). The low intracellular count of the ovine 
isolates opsonised with TBW 5 - IgG in comparison with the other isolates suggest 
that some of the substances present in this fluid may act specifically against ovine 
B. parapertussis thereby reducing macrophage uptake.
The increased bacterial uptake into macrophages following opsonisation may be 
due to invasion of the cells via an alternative route. Hazenbos et a l (1994) 
suggested that in the absence of opsonins, B. pertussis is internalised in monocytes 
via the RGD-CR3 interaction whereas in the presence of opsonins, the bacteria 
enter monocytes via Fc receptors. This may also be the case for the macrophage 
uptake of B. parapertussis.
Uptake via the CR3 receptor does not initiate the oxidative burst within 
macrophages (Wright and Silverstein, 1983). As a result, the bacteria will not be 
exposed to reactive oxygen intennediates which are bactericidal. Therefore, this 
route may promote intracellular suiwival of the bacteria. On the other hand, entiy 
into the macrophages via Fc receptors activates the respiratory burst which can 
then kill the bacteria.
The intracellular count of R. parapertussis presented in Table 5.3. was much lower
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than those in Table 5.1. This may be because the macrophages used in these 
experiments were isolated from different sheep, resulting in different intracellular 
counts and survival rates.
Comparison of the survival of ovine and human B. parapertussis within ovine 
alveolar macrophages revealed that HI was more capable of intracellular survival 
compared with K2, B285 and NCTC 10520 (Fig 5.3) . It is possible that the higher 
survival rate of HI is a result of better adherence and uptake into the macrophage 
compared with the other isolates. Alternatively, it may be that HI possesses higher 
concentrations of the virulence factors of B. parapertussis and is therefore better 
equipped to withstand the antimicrobial mechanisms within the macrophage. B. 
pertussis uses AC to increase intracellular cAMP thereby inhibiting the fusion of 
the B. pertussis-ooni^Lmmg phagosome and the lysosome and preventing killing of 
the bacteria (Masure, 1993). It is possible that HI produces more AC than the 
other isolates and utilises the same mechanism as B. pertussis for intracellular 
survival.
In contrast with B. pertussis, B. bronchiseptica survives within macrophages by a 
process which does not require the production of 6vg-activated virulence factors. 
B. bronchiseptica-oonXeimmg phagosomes fuse with the lysosome thereby exposing 
B. bronchiseptica to attack by antimicrobial products such as reactive oxygen 
metabolites and lysozyme. However, B. bronchiseptica survives the antimicrobial 
attack which suggests that this organism may produce virulence factors which are 
negatively-regulated by the BvgAS system in order to survive intracellularly 
(Banemann and Gross, 1997). The actual mechanism of B. parapertussis 
intracellular survival is unknown. As B. pertussis and B. bronchiseptica both use
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different methods of survival within the macrophage it would be useful to 
determine if B. parapertussis uses the same mechanism as one of the other 
bordetellae or if it has a unique survival strategy.
Opsonisation with a variety of fluids did not significantly affect the survival of B. 
parapertussis (Fig. 5.8-5.11). Fig. 5.9 shows that a proportion of the unopsonised 
ovine isolate K2 appears to survive intracellularly yet counts of intracellular 
bacteria carried out microscopically showed that, during this experiment, 
unopsonised K2 was not intracellular. It is possible that K2 is closely associated 
with the macrophage cell surface but not internalised. This may protect the 
bacteria from killing when antibiotics are added to the macrophage layer in order to 
kill extracellular bacteria and therefore these bacteria are included in the 
intracellular survival count. This type of protection has been obseiwed for the 
interaction of B. bronchiseptica with macrophage monolayers (Forde et al., 1998). 
Following 48 h incubation within ovine alveolar macrophages, the number of 
viable intracellular ovine B. parapertussis was begimiing to increase whereas the 
concentration of viable intracellular human B. parapertussis was in decline (Fig. 
5.12). The difference in the ability of human and ovine B. parapertussis to survive 
intracellularly may be due to host specificity of the isolates. Unfortunately, the 
suiwival of ovine and human isolates within h'esh human alveolar macrophages 
could not be studied to determine if the intracellular survival of B. parapertussis is 
host specific. However, porcine alveolar macrophages were used to determine if B. 
parapertussis survival within alveolar macrophages was host specific. If this was 
the case then you would expect the number of viable ovine and human B. 
parapertussis to decrease. Over the first 24 h, the viability of both ovine and
116
human B. parapertussis decreased (Fig. 5.13). This was followed by a continual 
decrease in viable ovine B. parapertussis for a further 24 h whereas the numbers of 
viable human B. parapertussis increased. It is possible that the increase of human 
B, parapertussis is the result of a release of nutrients from dead bacteria therefore 
enabling growth of the remaining viable bacteria. Alternatively, the recoveiy in 
viable numbers of human B. parapertussis could represent the selection of a small 
percentage of bacteria which are then able to grow because of the lack of 
competition from other bacteria within the macrophage.
Using an infection ratio of approximately 30 bacteria per cell, ovine B. 
parapertussis could suiwive and increase in numbers within ovine macrophages for 
48 h. Friedman et al. (1992) demonstrated that B. pertussis could survive 
intracellularly for 3 days at a infection rate of 100 bacteria per cell but required a 
ratio of 400 bacteria per cell for multiplication to occur. It has also been shown 
that the persistence of B. bronchiseptica within cultured murine macrophages was 
dependent upon the infectivity ratio. Forde et al. (1998) showed that B. 
bronchiseptica could survive within macrophages for 4 days, with little reduction 
in number, when an infectivity ratio of >500:1 (bacteri a : macrophages) was used. 
The 48 h incubation period in this study only permitted a study of short-term 
survival of B. parapertussis within macrophages. Investigation over a longer 
period of time might reveal the extent of Æ parapertussis intracellular survival and 
indicate the importance of this in the disease process.
For all of the phagocytic survival experiments, there were large margins of eiTor. It 
is likely that this was due to the fact that for each experiment, macrophages were 
isolated from a group of different sheep. Similar differences in bacterial survival
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were also noted by Wasswnaar et al. (1997) who stated that the viability of 
phagocytosed Campylobacter jejuni was dependent upon the individual donating 
the macrophage.
The experiments presented in this chapter suggest that there is a relationship 
between the adherence of B. parapertussis to macrophages and any subsequent 
invasion of these macrophages. However, analysis of the survival of B. 
parapertussis within macrophages revealed that despite the ovine isolates adhering 
to and invading ovine alveolar macrophages better than human isolates, neither of 
the ovine isolates survived intracellularly better than the human isolates.
It is clear that the interaction of B. parapertussis with host macrophages and the 
intracellular survival of these bacteria requires further study to determine if the 
mechanisms of these interactions are similar to those of B. pertussis or B, 
bronchiseptica or if B. parapertussis uses a different strategy. Further 
investigation, possibly using B. parapertussis mutants defective in the vimlence 
factors implicated in macrophage interaction, would deteimine the importance of 
intracellular survival in B. parapertussis disease.
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CHAPTER 6
COMPARISON OF OVINE AND HUMAN BORDETELLA 
PARAPERTUSSIS LIPOPOLYSACCHARIDE 
6.1. Introduction
Lipopolysaccharide (LPS) is a major component of the outer membrane of Gram- 
negative bacteria and one of the main virulence factors produced by these bacteria. 
Studies have revealed that the LPS of human B. parapertussis is smooth and 
consists of 0-antigen, which produces a ladder aiTangement of high molecular 
mass in addition to a region of low molecular mass on PAGE (Amano et al, 1990; 
Di Fabio et al, 1992). In comparison, the LPS of ovine B. parapertussis is 
reported to rough, consisting of only the core region which produces an area of low 
molecular mass on PAGE (van den Aklcer, 1998). However, little is known about 
the role of LPS in infections caused by Bordetella species, although the LPS of B. 
parapertussis has been reported to be less toxic than the LPS of B. pertussis and B. 
bronchiseptica (Watanabe et al, 1990).
This study was earned out to compare the PAGE-generated LPS profiles of ovine 
and human B. parapertussis and determine whether the LPS of ovine and human 
were immunologically distinct.
6.2. Materials and methods
The isolates used in this chapter are listed below in Table 6.1.
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Table 6.1. Strains of B. parapertussis used in LPS analysis
Ovine Human
C B285
HI NCTC 10520
K2 NCTC 5952
J1 B268
NZ 928 B271
The LPS of these bacteria were analysed using PAGE and Western blots. Ovine B. 
parapertussis HI and K2 and human B. parapertussis B285 and NCTC 10520 
were also used in bactericidal assays comparing the bactericidal activity of ovine 
and rabbit sera raised against ovine and human B. parapertussis. Further details of 
the materials and methods used can be found in sections 2.6 and 2.7.
6.3. LPS PAGE
LPS was extracted from nutrient broth and cyclodextrin liquid cultures of different 
B. parapertussis isolates. These were then compared using PAGE and visualised 
using a silver stain. The results are shown in Fig. 6.1 -  6.4.
The LPS of B. parapertussis grown in cyclodextrin liquid (Fig. 6.1 and 6.2) was 
different from the LPS of B. parapertussis grown in nutrient broth (Fig. 6.3 and 
6.4) when observed using PAGE.
The 12 % aciylamide gel of cyclodextrin liquid cultures (Fig 6.1) shows that the
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Fig. 6.1. 12 % acrylamide PAGE of LPS of ovine and human B. parapertussis 
extracted from cyclodextrin liquid cultures visualised using silver staining. Ovine 
isolates lanes 1-5 and human isolates lanes 6-10. Lane order: (1) HI, (2) K2, (3) C, 
(4) Jl, (5) NZ 928, (6) B 285, (7) NCTC 5952, (8) NCTC 10520, (9) B268, (10) 
B271.
Fig. 6.2. 14 % aciylamide PAGE of LPS of ovine and human B. parapertussis 
extracted from cyclodextrin liquid cultures visualised using silver staining. Ovine 
isolates lanes 1-5 and human isolates lanes 6-10. Lane order: (1) HI, (2) K2, (3) C, 
(4) Jl, (5) NZ 928, (6) B 285, (7) NCTC 10520, (8) NCTC 5952, (9) B268, (10) 
B271.
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Fig. 6.3. 12 % aciylamide PAGE of LPS of ovine and human B. parapertussis 
extracted from nutrient broth cultures visualised using silver staining. Ovine 
isolates lanes 1-5 and human isolates lanes 6-10. Lane order: (1) HI, (2) K2, (3) C, 
(4) Jl, (5) NZ 928, (6) B 285, (7) NCTC 5952, (8) NCTC 10520, (9) B268, (10) 
B271.
Fig. 6.4. 14 % aciylamide PAGE of LPS of ovine and human B. parapertussis 
extracted fi'om nutrient broth cultures visualised using silver staining. Ovine 
isolates lanes 1-5 and human isolates lanes 6-10. Lane order: (1) HI, (2) K2, (3) C, 
(4) Jl, (5) NZ 928, (6) B 285, (7) NCTC 5952, (8) NCTC 10520, (9) B268, (10) 
B271.
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ovine isolates contained only a low molecular weight area, presumably the core 
region of the LPS whereas 4 out of 5 of the human isolates also contained higher 
molecular mass structures. Two of the human isolates (B285 and NCTC 10520) 
clearly show a ladder arrangement of 0-antigens. Another two of the human 
isolates (B268 and B271) displayed a band in the same region of the 0-antigens of 
B285 and NCTC 10520 but no ladder arrangement was discernible. It is 
interesting to note that the human isolate NCTC 5952 has an LPS pattern similar to 
those of the ovine isolates.
The 14 % acrylamide gel of cyclodextrin liquid cultures (Fig. 6.2) revealed that the 
core region of the LPS extracted fi*om ovine isolates consisted of at least two 
distinct low molecular weight bands compared with the one distinct low molecular 
weight band found in the LPS of most of the human isolates, again with the 
exception of NCTC 5952 which had an profile similar to those of the ovine 
isolates.
Analysis of LPS extracted from nutrient broth cultures in 12% and 14% acrylamide 
gels (Fig. 6.3 and 6.4) showed that the ovine isolates consisted of a single low 
molecular weight band whereas the human isolates contained a single low 
molecular weight band and a single band of a higher molecular weight. No ladder 
arrangement could be discerned within the higher molecular weight bands. On the 
12% gel the ovine isolate C and human isolate NCTC 5952 both produced faint 
bands at a high molecular weight, but lower than those found in the other human B. 
parapertussis LPS, as well as a low molecular weight band. In comparison, the 
LPS of both of these isolates consisted of a single low molecular weight band on 
the 14% gel.
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6.4. Western blots of LPS
The LPS extracted from cyclodextrin cultures of both ovine and human B. 
parapertussis were mn on a 12% acrylamide gel then transferred onto 
nitrocellulose membrane and probed with a range of different sera. The sera used 
are listed below.
Table 6.2. Sera raised against B. parapertussis.
Rabbit sera Sheep sera
Anti-.S. parapertussis isolate C (No. 355) Anti-5. parapertussis isolate HI (No. 39)
AntL.5. parapertussis NCTC 10520 Anti-R. parapertussis 1::^ CTC 10520
(No.38) (No.227)
The resulting blots using rabbit sera are pictured in Fig. 6.5 and 6.6. Nothing was 
observed on the blots probed with sheep sera.
Rabbit serum raised against ovine isolate C recognised weakly all the ovine and 
human isolates on a Western blot (Fig. 6.5), although it did not recognise the O- 
antigens of the human isolates B285 and NCTC 10520.
In comparison, the rabbit serum raised against the human isolate NCTC 10520 
recognised only the human B. parapertussis isolates. However, this serum 
recognised neither the human isolate NCTC 5952 nor the ovine isolates. This 
serum reacted with only the higher molecular weight bands that could be seen on a 
silver stain of the human isolates. The ladder arrangement of B 285 and NCTC 
10520 can be seen on the Western blot.
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Fig. 6.5, Western blot of ovine and human Bordetella parapertussis LPS probed 
with rabbit sera raised against ovine isolate C. Ovine isolates lanes 1-5 and human 
isolates lanes 6-10. Lane order: (1) HI, (2) K2, (3) C, (4) Jl, (5) NZ 928, (6) 
B285, (7) NCTC 10520, (8) NCTC 5952, (9) B268, (10) B271.
Fig. 6.6. Western blot of ovine and human Bordetella parapertussis LPS probed 
with rabbits sera raised against human isolate NCTC 10520. Ovine isolates lanes 
1-5 and human isolates lanes 6-10. Lane order: (1) HI, (2) K2, (3) C, (4) Jl, (5) 
NZ 928, (6) B285, (7) NCTC 10520, (8) NCTC 5952, (9) B268, (10) B271.
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6.5. Bactericidal Assay
Bactericidal assays were carried out to detemiine if the sera used for probing the 
LPS of B. parapertussis on Western blots were bactericidal to the ovine and human 
isolates of B. parapertussis tested. Test sera were heat-inactivated at 56°C for 30 
mill, added to a bacterial suspension followed by the addition of an exogenous 
source of complement (specific-pathogen-free lamb serum). This mixture was 
incubated for 45 min at 37°C then samples were taken and plated onto blood agar 
to detennine the number of viable bacteria remaining. The results are tabulated in 
Table 6.3.
From this table it is clear that the complement source alone (PBS + complement) 
kills 100% of K2 and a proportion of the other bacteria. To compensate for this 
difference, the percentage of bacteria killed by the complement alone was 
subtracted from the percentage killed to give a more accurate reflection of the 
bactericidal effects of the sera tested. These results are displayed in Table 6.4. 
These results show that, as with the Western blots of LPS using these sera, the sera 
raised against ovine B. parapertussis killed approximately the same amount of both 
ovine and human B. parapertussis. In comparison, sera raised against human B. 
parapertussis killed a much higher percentage of human isolates compared to 
ovine isolates.
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Table 6.3. Percentage of ovine (HI and K2) and human (B285 and NCTC 10520) 
B. parapertussis killed by various sera.
Percentage killing of isolate:
Sera HI K2 B285 NCTC 10520
Mean ± SEM Mean ± SEM Mean ± SEM Mean ± SEM
Sheep a  HI 96.47 ± 1.97 100 ± 0 96.43 ±1.82 92.5 ±5.12
Sheep a  NCTC 10520 58.9 ± 10.1 100 ±0 100 ± 0 100 ± 0
Rabbit a  C 68.6 ± 10.5 100 ±0 25.3 ± 11.4 15.2 ±7.81
Rabbit a  NCTC 10520 
Controls
61.77 ±2.89 100 ±0 100 ± 0 100 ± 0
PBS + complement 53.4 ± 12.3 100 ±0 36.9 ± 12.9 35.1 ±13.2
Heat-inactivated 
complement ± sheep aH l
1.37 ± 1.37 12.6 ± 7.08 15.6 ± 10.8 11.7±7.31
Heat-inactivated 
complement ± sheep a  
NCTC 10520
0 ± 0 8.9 ± 6.86 19.1 ± 12.2 9.07 ±9.07
Heat-inactivated 
complement + rabbit a  C
9.53 ±7.89 6.2 ± 0.86 31.97 ±9.37 28.4 ± 15
Heat-inactivated 
complement + rabbit a  
NCTC 10520
3.73 ± 1.87 11.3 ±6.28 30.07 ±9.32 28.6 ± 15.5
Table 6.4. Percentage of ovine (HI and K2) and human (B285 and NCTC 10520) 
B. parapertussis killed by various sera following the subtraction of the percent 
killed by the complement source alone.
Sera
Sheep a  HI
Sheep a  NCTC 10520
Rabbit a  C
Rabbit a  NCTC 10520
6.6 Discussion
HI
Mean ± SEM 
43T+1ÔY" 
6.27 ±5.02 
15.23 ± 1.93 
12.2 ± 6.10
Percentage killing of isolate: 
K2 B 285
Mean ± SEM Mean ± SEM
0 ± 0
0 ± 0
0 ± 0
0 ± 0
65.1 ± 17.9
68.7 ± 16.3 
0 ± 0
68.7 ± 16.3
NCTC 10520 
Mean ± SEM 
""7 7 A T Ï 6....
66.9 ± 13.2 
5.03 ±5.03
66.9 ± 13.2
PAGE of the LPS of B. parapertussis revealed differences in LPS produced in 
cyclodextrin liquid when compared with the LPS produced in nutrient broth. The 
LPS of four out of five human B. parapertussis produced a high molecular weight
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ïband when extracted from both cyclodextrin liquid and nutrient broth cultures. 
However, O-antigens could only be visualised on two of the isolates (B285 and 
NCTC 10520) when they were grown in cyclodextrin liquid (Fig. 6.1). The LPS of 
ovine isolates grown in cyclodextrin liquid produced tlmee bands, two of which 
foiTned the core region and another that was of a higher molecular weight (Fig. 
6.2). In compai'ison, the LPS of ovine isolates grown in nutrient broth consist of a 
single low molecular weight band (Figure 6.4). This implies that the structure of 
the LPS when visualised on PAGE gel is dependent on the medium used to grow 
B. parapertussis, A study of Bacteroides species (Allan and Poxton, 1994) also 
revealed that the growth medium used affects the LPS pattern that is produced on 
PAGE.
The LPS of human B. parapertussis has been previously described as consisting of 
low molecular mass bands together with a ladder an’angement of high molecular 
mass bands (Amano et al, 1990; Di Fabio et al, 1992). Only two out of the five 
human isolates tested (B285 and NCTC 10520) displayed this LPS pattern (Fig. 
6.1). However, a further two human isolates (B268 and B271) appeared to contain 
a high molecular weight band in the same region as the ladder aiTangement of 
B285 and NCTC 10520. It is possible that better resolution of this band would 
reveal a ladder arrangement similar to those seen in the other isolates, van den 
Akker (1998) reported that growth temperature affected the LPS profile of B. 
parapertussis isolates. A reduction in temperature from 37°C to 25°C resulted in 
the absence of a ladder of O-antigens on the LPS of human B. parapertussis but 
this was replaced by a faster-migrating O-antigen containing a single band. This is 
similar to the LPS profile of B268 and B271 and it may be that growth of these
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isolates at a different temperature will result in a ladder aiTangement of O-antigens. 
In contrast, the LPS of all the ovine isolates and the human isolate NCTC 5952 
appeared to be of the rough type i.e. no O-antigens were seen. The presence of O- 
antigens in the LPS of most of the human B. parapertussis and their absence in the 
LPS of ovine B. parapertussis reflects the findings of van den Akker (1998) who 
also detemiined that the LPS type of B. parapertussis was host specific. Yet, in 
this study, the LPS of the human isolate NCTC 5952 had a similar profile to the 
ovine isolates therefore questioning the suggestion that the LPS of B. parapertussis 
is ho St-specific. This is supported by the analysis of B. parapertussis LPS using 
anti-LPS monoclonal antibodies which resulted in NCTC 5952 being grouped with 
ovine isolates rather than the other human isolate tested (Porter et al, 1995c). It 
would be useful to screen a larger sample of human and ovine B. parapertussis to 
determine the prevalence of rough-type LPS.
Different LPS types from the same host species have also been described for B. 
bronchiseptica (Le Blay et al, 1997; van den Alcker, 1998). Le Blay et a l (1997) 
suggested that the vaiiability of LPS structures of B. bronchiseptica from the same 
host species could occur to evade the immune response and that the smooth LPS 
may correspond to a primary infection whereas the rough LPS may coiTespond to a 
recurrent or clironic infection. This could also be the case for B. parapertussis as 
ovine B. parapertussis isolated from apparently healthy sheep (Cullinane et al, 
1987; Porter et a i, 1994) was reported to cause a subclinical infection in mice 
(Chen et al, 1989) and sheep (Porter et <3/., 1995a). This could explain the presence 
of only rough LPS on B. parapertussis isolated from sheep.
The Western blots of LPS from B, parapertussis revealed different specificities of
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the sera used. The rabbit sera raised against the ovine B, parapertussis isolate C 
recognised the core region of all the isolates tested (Fig. 6.5) whereas the rabbit 
sera raised against the human isolate NCTC 10520 recognised only the O-antigens 
of the human B. parapertussis tested (Fig. 6.6). The sera raised against human B. 
parapertussis did not recognise the core region of any of the isolates and as such 
did not recognise the human isolate NCTC 5952. The lack of recognition of the 
core region of B, parapertussis LPS with this sera suggests that when the host 
comes into contact with smooth LPS of B, parapertussis the O-antigens mask the 
core region and therefore only an immune response against the O-antigens is 
raised. The absence of O-antigens on ovine LPS could explain why rabbit sera 
raised against the ovine isolates recognises both ovine and human LPS as all the 
isolates tested presented a core region on a silver stain of the LPS gel. This could 
also explain why the O-antigens on the human isolates are not recognised by sera 
raised against ovine isolates.
Ovine sera raised against ovine and human B. parapertussis did not recognise any 
of the B. parapertussis LPS on a Western blot. This may be because to raise ovine 
sera against these isolates, live bacteria were inoculated into the sheep. This could 
result in the bacteria masking the LPS or it could be that LPS is non-immunogenic 
in sheep. In comparison, the rabbits were inoculated with formalin-killed bacteria 
plus an adjuvant. In this state the LPS of the bacteria may be exposed and the 
presence of an adjuvant would enliance any immune response to the virulence 
factors present.
The use of a bactericidal assay to detemiine if the sera used to probe Western blots 
for LPS were bactericidal to ovine and human B. parapertussis revealed that the
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isolates tested were sensitive to the complement source (Table 6.3). B. 
parapertussis has been reported to have a serum resistance locus (ô/Vc) (Fernandez 
and Weiss, 1994) although it is thought to be transcriptionally silent. Therefore 
this is unlikely to affect the complement killing of the B, parapertussis isolates 
tested here. The presence of O-antigens on the LPS of Bordetella species has been 
suggested to protect the bacteria from antibody and complement-mediated killing 
(Byi'd et aL, 1991). The absence of O-antigens on the LPS of a B. bronchiseptica 
was detennined to be the reason why this strain was sensitive to unheated pre­
colostrum sera and hyperimmune porcine sera. However, despite the presence of 
O-antigens on the LPS of the human isolates B285 and NCTC 10520 
approximately 35% of these bacteria were killed by complement alone. A higher 
percentage of the ovine strains (53% and 100%) were killed by the complement 
source and as these bacteria had rough LPS it is possible that the LPS does play a 
role in protecting B. parapertussis from complement killing. However, other 
factors must also be involved. Colostrum-deprived SPF lamb sera was used as the 
complement source and as such, no antibodies should be present. Therefore, it is 
possible that the bacteria activate the alternative complement pathway resulting in 
the serum complement killing the bacteria.
The percentage killing of bacteria by the various sera (Table 6.4) revealed that sera 
raised against the human isolate NCTC 10520 were more bactericidal for the 
human isolates than the ovine isolates. In comparison, there was little difference in 
the bactericidal effects of sera raised against ovine B, parapertussis on both ovine 
and human isolates. This reflects the reaction of rabbit sera with Western blots of 
LPS from these bacteria (Fig. 6.5 and 6.6) where the sera raised against an ovine
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isolate reacted with all the isolates yet sera raised against a human isolate only 
reacted with the human isolates. These findings suggest a possible role for LPS as 
a target for the bactericidal activity of sera.
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CHAPTER 7
GENERAL DISCUSSION
This study was designed to compare ovine and human B. parapertussis with 
particular reference to the possibility of host specificity of these isolates. In the 
context of this thesis, B. pertussis and B. bronchiseptica were discussed as 
comparators for B. parapertussis. These species have been shown to be so closely 
related (De Ley et al, 1986; van der Zee et a l, 1997) and have been extensively 
researched that comparison with these was of more immediate relevance than with 
other unrelated bacterial species.
Ovine tracheobronchial washings (TBW) were used as growth media for ovine and 
human isolates to determine any host preference in the survival of B. parapertussis. 
The work presented here showed that there was possible host specificity of ovine 
and human B. parapertussis in their ability to grow in ovine TBW. Moreover, the 
results suggested that the potential for growth of B. parapertussis in these TBW 
was dependent upon the sheep that the TBW were taken from. The different 
growth rates of ovine and human B. parapertussis in the 5 TBW and the differing 
intracellular count and suiwival rates of these bacteria within ovine alveolar 
macrophages do suggest that each sheep reacts differently to the presence of these 
bacteria and this may depend upon prior exposure to B. parapertussis. It would be 
interesting to screen more sheep for the presence of B. parapertussis and monitor 
how exposure to B. parapertussis affects both the growth of this bacterium in TBW 
and interaction with macrophages taken from the sheep that the B. parapertussis
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strain was isolated from.
The use of nutrient broth (NB) as a positive control for the growth of ovine and 
human B. parapertussis revealed that human isolates of B. parapertussis were 
slower growing than ovine B. parapertussis. This suggests that ovine and human 
B. parapertussis have different nutritional requirements and it may be that human 
B. parapertussis are more fastidious than the ovine isolates.
Further work is needed to fully ascertain the reason for the differing growth rates of 
ovine and human B. parapertussis in the variety of fluids tested. Perhaps, these 
isolates have different requirements for nicotinic acid and essential amino acids.
Assaying the presence of these factors in TBW and NB and monitoring the growth 
of ovine and human B. parapertussis in vaiying concentrations of these factors 
might help to resolve this question. It may also be that ovine and human B. 
parapertussis have different susceptibilities to antibacterial factors present in TBW 
and monitoring the growth of these isolates in varying concentrations of factors 
such as lung surfactant, lysozyme, fatty acids and lactofenin may reveal the reason 
for the different growth rates observed. It is also possible that, because these 
factors may be present in ovine TBW, the ovine isolates may possess mechanisms 
which could overcome these antibacterial proteins whereas the human isolates may 
be susceptible.
The suggestion of host specificity of ovine and human B. parapertussis could be 
further studied by monitoring the growth of these isolates in human TBW. This Î
work could also benefit from the use of a wider range of ovine and human B. 
parapertussis strains which would give a better indication of any host specificity.
Adherence to the host respiratory tract is an important step in the establislrment of
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B. parapertussis infection. Previous studies have shown that the adherence of 
human B. parapertussis to ciliated epithelial cells demonstrates some host 
specificity (Tuomanen et aL, 1983). The results of the present study suggested that 
the adherence of ovine B. parapertussis to ovine tracheal organ culture was host 
specific. However, the adherence to continuous cell culture lines did not reveal 
host specificity of the ovine and human B. parapertussis. These cells are non- 
ciliated whereas B. parapertussis nonnally adheres to cilia of the host tracheal 
epithelium (Tuomanen et al., 1983). Therefore, the ovine tracheal organ culture 
assay used in this project more closely resembles an in vivo situation. An 
interesting comparison would be to study the adherence of a greater number of 
ovine and human B. parapertussis strains to both ovine and human tracheal organ 
culture to determine if the adherence of ovine and human B. parapertussis to 
trachea is indeed host specific.
Investigation into the invasive potential of ovine and human B. parapertussis 
suggested that the invasion of cells by B. parapertussis was dependent upon 
adherence to these cells. Ovine isolate HI was more adherent and invasive than 
the other isolates. HI also appeared to produce more FHA therefore reinforcing 
the suggestion that this protein is an important vimlence factor of B. parapertussis. 
FHA is not the only potential adhesin produced by ovine and human B. 
parapertussis. The adherence assays revealed differences in the ability of the two 
human isolates (B285 and NCTC 10520) to adhere to both cell lines and ovine 
tracheal organ culture despite both these isolates producing similar levels of 
haemagglutinin, presumably FHA. This raised the question of a possible role for 
other adhesins, such as PRN and fimbriae, in the adherence of human B.
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parapertussis. It is also likely that these virulence factors are produced to enhance 
the adherence capabilities of ovine B. parapertussis. The development of specific 
assays to measure for PRN, fimbriae and FHA as well as the use of monoclonal 
antibodies raised against these factors would establish how essential these proteins 
are for the adherence of .5. parapertussis to different target cells. The production 
of mutants defective in these virulence factors, by using site-directed mutagenesis, 
would be useful in the study of their role, if any, in the adherence of B. 
parapertussis.
In the present study, incubation of P. haemolytica with B. parapertussis culture 
fluid did not increase the adherence of P. haemolytica. It may be that, unlike B. 
pertussis, B. parapertussis does not contribute to the adherence of other bacteria to 
the respiratory tract. The results presented in this study suggest that B. 
parapertussis and P. haemolytica adhesins compete for the same receptors. 
However, it is possible that the production of other B. parapertussis virulence 
factors may enhance P. haemolytica infection.
Human B. parapertussis strains produce TCT and HLT which are capable of 
damaging the ciliated epithelial cells of the respiratory tract. This could predispose 
the host to a secondaiy infection by another respiratoiy pathogen. It may be that 
ovine B. parapertussis also produce these toxins and the action of these enable P. 
haemolytica to cause disease. If these factors are produced by ovine B. 
parapertussis then the establishment of mutants defective in these toxins followed 
by their use in organ culture or sheep which are then infected with P. haemolytica 
may determine their role in the predisposition of sheep to P. haemolytica infection. 
Porter et al. (1995a) demonstrated that B. parapertussis predisposed specific
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pathogen-free (SPF) lambs to P. haemolytica infection but that B. parapertussis 
alone did not result in any signs of clinical disease. However, Porter et al. (1995a) 
used ovine B. parapertussis isolate C which has subsequently been shown to be 
less adherent to cell lines than both the ovine isolates, HI and K2, used in this 
current study (F. McCallum, personal communication). It is possible that the use 
of an apparently more virulent strain, such as HI, would result in greater 
predisposition of SPF lambs to P. haemolytica which, in turn, may cause a more 
severe infection than observed by Porter et ah (1995a). It is also possible that 
infection of SPF lambs with ovine B. parapertussis isolate HI alone may result in 
some signs of clinical disease.
Analysis of the LPS produced by ovine and human B. parapertussis revealed that 
all the ovine isolates tested had rough-type LPS whereas the majority of the human 
isolates had smooth-type LPS. The one exception was NCTC 5952 which is the 
type strain of B. parapertussis and was isolated from a case of whooping cough. 
These results conflicted with an earlier report (van den Akker, 1998) which stated 
that ovine and human B. parapertussis have different LPS structures. The 
interaction of B. parapertussis LPS with rabbit sera raised against ovine and 
human B. parapertussis did suggest that LPS may be immunogenic and possibly a 
target of bactericidal activity. A bactericidal assay using sera absorbed with LPS 
would clarify whether anti-LPS antibodies are an important part of the host 
immune defence against B. parapertussis infection.
An interesting observation was that the pattern of LPS visualised on a silver- 
stained PAGE gel varied depending on the growth medium used. A study of the 
LPS produced by ovine and human B. parapertussis grown in a variety of different
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fluids, such as ovine and human TBW, lamb serum and human serum, may reveal 
further variation of B. parapertussis LPS and the use of in vivo fluids may 
determine the LPS pattern produced during infection.
Analysis of interaction between alveolar macrophages and B. parapertussis 
showed that the isolates which were more adherent to macrophages were also more 
easily taken up by macrophages. This also reflects the findings in chapter 4 where 
the isolates which were more adherent to MRC-5 cells were also more invasive. In 
this study, both the ovine isolates adhered to and invaded ovine alveolar 
macrophages better than human isolates thereby suggesting some host specificity. 
However, the survival of any intracellular bacteria did not follow the same pattern. 
Instead, the survival of B, parapertussis within macrophages was possibly 
dependent upon the production of virulence factors. Ovine isolate HI produced 
more haemagglutinin, presumably FHA, than the other isolates and as most of the 
virulence factors of B. parapertussis are regulated by the èvg-operon, it is likely 
that HI will also produce more of the other virulence factors. The production of 
these virulence factors and other proteins may result in the better suiwival of HI 
within alveolar macrophages compared to the other isolates tested.
This study highlighted the importance of the production of vimlence factors by B. 
parapertussis. Throughout this project, ovine B. parapertussis HI stood out as the 
isolate most capable of growth in in vivo fluids, adherence to and invasion of cells 
and survival within macrophages. It is known that this isolate produces more 
haemagglutinin, presumably FHA, than the other isolates and it is possible that HI 
also produces more of the known B. parapertussis vimlence factors. Measurement 
of these other virulence factors, production of antibodies against them and
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development of mutants defective in their production may reveal their role in the 
pathogenicity of ovine B. parapertussis and their possible role in the predisposition 
of sheep to P. haemolytica infection.
The growth studies, adherence to tracheal organ culture and adherence to and 
invasion of alveolar macrophages have all suggested possible host specificity of 
ovine and human B. parapertussis. This project was limited in the study of host 
specificity because only ovine tissues and fluids were accessible. For an accurate 
comparison of potential host specificity of ovine and human B. parapertussis to be 
carried out, the interaction of both these types of B. parapertussis with both human 
and ovine tissues and fluids must be studied. It has been suggested by van der Zee 
et al. (1996) that ovine and human B. parapertussis evolved separately fiom B. 
bronchiseptica. This may explain the possible host specificity of the isolates tested 
in this project.
Any further comparison of ovine and human B. parapertussis should comprise of 
more strains and include the human isolate NCTC 5952. In this study, NCTC 5952 
produced the same LPS profile as ovine B. parapertussis. Previous work has also 
shown NCTC 5952 to have antibiotic sensitivities similar* to ovine B. parapertussis 
(Porter et al., 1995) and a PFGE banding pattern identical to ovine B. parapertussis 
(Porter et ah, 1996). Further study of this isolate may reveal more about the 
evolution of ovine and human B. parapertussis and the potential of any cross- 
infection caused by these isolates.
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APPENDIX I
Bordet-Gengou agar
15 g Bordet-Gengou agar base
5 g Glycerol
75 ml Sheep blood
500 ml Distilled water
Cyclodextrin liquid (as Imaizumi et «A, 1983)
Basic medium
10.7 g Sodium 1-glutamate
2.5 g NaCl
0.5 g KH2PO4
0.1 g MgCri.dH^O
0 .0 2  g CaClz
0 .2  g KCl
6.1 g Tris
0.5 g Casamino acids
0.24 g L-proline
1 g Heptakis(2,6-di-0-methyl)-p-cyclodextrin
1 1 Distilled water
Adjust to pH 7.4. Sterilise at 121°C for 15 min. Before use, add lOOpl of supplement 
to 10ml of cyclodextrin liquid.
Supplement
0.01  g FeSO^
0.04 g L-cysteine
0.004g Niacin 
0.15 g Glutathione
0.02 g Ascorbic acid
10 ml Distilled water
Filter sterilise using a 0.45pm filter. Store at -20°C for up to 3 months.
SDS-PAGE for protein detection 
4 X 0.75mm 10% gels (BIO-RAD Mini-PROTEAN II electrophoresis system)
Resolving gel
7.85 ml Distilled water
5 ml Buffer (1.91 g Tris, 0.4 g SDS, distilled water to 100ml, pH 8 .8)
6.35 ml Acrylamide (30%)
1.11 g Sucrose
7.5 pi TEMED
7.5 pi Ammonium persulphate ( 10%)
Stacking gel
Make up to 1 1 with distilled water 
Coomassie blue
1 ml Coomassie brilliant blue R250 (Sigma)
100 ml Glacial acetic acid
500 ml Methanol
400 ml Distilled water
Dissolve overnight and filter tlrrough a Wliatman No. 1 filter paper. Pour directly onto 
the gel and stain for a minimum of 2  h.
3 #
4 ml Distilled water f
5 ml Buffer (3.03 g Tris, 1 g SDS, water to 100 ml, pH 6.8
1 ml Acrylamide (30%)
10 pi TEMED i
75 pi Ammonium persulphate (10%)
Electrode buffer ;
14.4 g Glycine
3.03 g Tris
1 g SDS
'I;
Destain for Coomassie blue
70 ml Glacial acetic acid
230 ml Methanol
400 ml Distilled water
Western blotting of SDS-PAGE mini gels 
(BIO-RAD Mini trans-blot electrophoretic transfer system)
Electrode buffer
3 g Tris
14,42 g Glycine
250 ml Methanol
Make up to 1 1 with distilled water
Blot wash buffer
5 ml Tween
0.37 g EDTA
20.45 g NaCl
100 ml 10 X PBS (400 g NaCl, 10 g KCl, 57.5 g Na^HPO ,^ 10 g KH^PO^,
distilled water to 5 L)
Make to 1 1 with distilled water 
199S medium
40 ml lOx 199 medium
400 ml Sterile distilled water
60 ml Tryptose phosphate broth
2.6 ml 8% Sodium bicarbonate
Before use, add 10% foetal bovine serum (FBS) and 1% glutamine
Eagles minimum essential medium (EMEM) for MRC-5 cells
500 ml EMEM
5 ml Basic amino acid solution
Before use, add 10% FBS.
EMEM for tracheal organ culture
500 ml EMEM
50 mi FBS
5 ml HEPES (2.5 M)
Cell lysis solution
17.6 ml PBS
2 ml S aponin ( 10%)
400 pi FBS
Sterilise using a 0.45pm filter before use.
RPM I1640
164 ml RPMI 1640
2 0  ml FBS
4 ml Glutamine (14.6 g 1"')
2  ml Pen/Strep (10000 U ml'V 10000 pg ml"’)
3 ml Nystatin (10000 U ml"’)
1 ml Mercaptoetlianol (10 pi in 10 ml PBS)
5 ml Sodium bicarbonate (8%)
2.4 ml HEPES (2.5M)
PAGE for detection of EPS 
4 X 0.75 mm gels (BIO-RAD Mini-PROTEAN II electrophoresis system)
Electrode buffer same as for SDS-PAGE (1.1)
Resolving gel 02%)
2.6 ml Distilled water
8.75 ml Double strength buffer (90.855 g Tris, 1 L distilled water, pH 8 .8)
5.25 ml Acrylamide (40%)
25 pi TEMED
0.875 ml Ammonium persulphate ( 1.5%)
Resolving gel G 4%)
1.725 ml Distilled water
8.75 ml Double strength buffer (90.855g Tris, 1 L distilled water, pH 8 .8)
6.125 ml Acrylamide (40%)
25 pi TEMED
0.875 ml Ammonium persulphate (1.5%)
Stacking gel (4%')
3.5 ml Distilled water
5 ml Double strength buffer (3.03 g Tris, 100 ml distilled water, pH 6 .8)
1 ml Acrylamide (40%)
20 pi TEMED
0.5 ml Ammonium persulphate (1.5 %)
Western blotting of LPS PAGE gels
(BIO-RAD Mini trans-blot electrophoretic transfer system)
Electrode buffer same as for western blotting of SDS-PAGE gels (1.2)
Tris-buffered saline (TBS)
4.84 g Tris
58.48 g NaCl
2 1 Distilled water
Dissolve Tris and NaCl in approximately 1.5 1 of water. Adjust pH to 7.5 and make up 
to 2 1.
Tween Tris-buffered saline (TTBS)
To 2 1 of TBS add 0.5 ml of Tween 20.
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